Intranasal corticosteroids are considered the optimal first-line treatment for allergic rhinitis. They are more effective than oral antihistamines, intranasal antihistamines, cromolyn sodium, or decongestants. Allergic rhinitis is diagnosed based on symptoms, allergy testing, and ruling out other causes of nasal congestion and drainage. Treatment involves identification and avoidance of allergens, intranasal corticosteroids, oral antihistamines, and immunotherapy for persistent or severe cases.
This document provides an overview of common pediatric respiratory illnesses discussed over 9 sections. Section 1 covers acute respiratory infections, distinguishing between upper and lower respiratory infections. Pneumonia is then discussed in section 2, covering etiology, clinical features, diagnosis, and treatment approaches. Section 3 focuses on bronchiolitis, describing the viral etiology, pathophysiology, clinical presentation, and differential diagnosis. Key points covered include that bronchiolitis most commonly affects infants under 2 years old and is predominantly caused by respiratory syncytial virus.
This document discusses respiratory tract infections, which are infections that involve the respiratory tract. It describes upper respiratory tract infections such as sinusitis, pharyngitis, and otitis media, and lower respiratory tract infections such as bronchitis, bronchiolitis, and pneumonia. For each infection, it discusses the typical causative agents, affected age groups, characteristics, clinical features, and treatment approaches. It provides an overview of the pathophysiology of upper and lower respiratory tract infections.
This document outlines protocols for treating various types of pneumonia, including community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and aspiration pneumonia. It details definitions, clinical features, common pathogens, investigations and workup, severity assessments, empirical antibiotic treatment options and durations, and monitoring considerations for each type. Empirical treatment regimens are tailored based on severity and risk factors. Duration of treatment typically ranges from 7-10 days but may be longer for complicated cases.
This document discusses various respiratory tract infections, including upper and lower respiratory tract infections. It covers topics such as otitis media (ear infection), pharyngitis (sore throat), sinusitis, bronchitis, bronchiolitis, and pneumonia. For each condition, it discusses etiology, clinical manifestations, diagnosis, treatment goals, and specific treatment options. Risk factors, pathogenesis, and monitoring of treatment response are also covered for some conditions. The document provides an overview of common respiratory infections seen in clinical practice.
This document provides an overview of pneumonia, including its causes, symptoms, diagnosis, treatment, and prevention. It defines pneumonia as an inflammation of the lung tissue that is often caused by infection. The main causes are bacterial, viral, fungal or parasitic microorganisms. Symptoms include cough, fever, chest pain, and difficulty breathing. Diagnosis involves physical exam, chest x-rays, culture of respiratory secretions. Treatment focuses on treating the underlying infection with antibiotics and supporting respiratory function. Prevention involves good hygiene, vaccination against influenza, and not smoking.
This document discusses pneumonia in children. It defines pneumonia and describes different types including lobar, bronchopneumonia, and interstitial pneumonia. The pathogens causing pneumonia vary by a child's age. Clinical manifestations depend on age with neonates showing subtle signs and older children showing fever, cough, and difficulty breathing. Investigations may include blood tests, chest x-rays, and culture of respiratory samples. Treatment depends on severity but usually involves antibiotics, oxygen, and hospitalization for severe or complicated cases. World Health Organization guidelines recommend oral amoxicillin for non-severe cases and injectable antibiotics for severe or non-responding cases.
1) A 2-year-old male child, KW, was admitted with a 3-day history of cough but no difficulty breathing, fever, or other symptoms.
2) On examination, KW had an increased respiratory rate of 70 bpm and abnormal bloodwork. He was diagnosed with bronchopneumonia.
3) KW's treatment plan included intravenous ampicillin, gentamicin, and hydrocortisone for 5 days to treat the bronchopneumonia. By day 2, his symptoms had improved and he was continuing on the antibiotic treatment plan with the goal of discharging him on oral amoxicillin.
This document provides an overview of common pediatric respiratory illnesses discussed over 9 sections. Section 1 covers acute respiratory infections, distinguishing between upper and lower respiratory infections. Pneumonia is then discussed in section 2, covering etiology, clinical features, diagnosis, and treatment approaches. Section 3 focuses on bronchiolitis, describing the viral etiology, pathophysiology, clinical presentation, and differential diagnosis. Key points covered include that bronchiolitis most commonly affects infants under 2 years old and is predominantly caused by respiratory syncytial virus.
This document discusses respiratory tract infections, which are infections that involve the respiratory tract. It describes upper respiratory tract infections such as sinusitis, pharyngitis, and otitis media, and lower respiratory tract infections such as bronchitis, bronchiolitis, and pneumonia. For each infection, it discusses the typical causative agents, affected age groups, characteristics, clinical features, and treatment approaches. It provides an overview of the pathophysiology of upper and lower respiratory tract infections.
This document outlines protocols for treating various types of pneumonia, including community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and aspiration pneumonia. It details definitions, clinical features, common pathogens, investigations and workup, severity assessments, empirical antibiotic treatment options and durations, and monitoring considerations for each type. Empirical treatment regimens are tailored based on severity and risk factors. Duration of treatment typically ranges from 7-10 days but may be longer for complicated cases.
This document discusses various respiratory tract infections, including upper and lower respiratory tract infections. It covers topics such as otitis media (ear infection), pharyngitis (sore throat), sinusitis, bronchitis, bronchiolitis, and pneumonia. For each condition, it discusses etiology, clinical manifestations, diagnosis, treatment goals, and specific treatment options. Risk factors, pathogenesis, and monitoring of treatment response are also covered for some conditions. The document provides an overview of common respiratory infections seen in clinical practice.
This document provides an overview of pneumonia, including its causes, symptoms, diagnosis, treatment, and prevention. It defines pneumonia as an inflammation of the lung tissue that is often caused by infection. The main causes are bacterial, viral, fungal or parasitic microorganisms. Symptoms include cough, fever, chest pain, and difficulty breathing. Diagnosis involves physical exam, chest x-rays, culture of respiratory secretions. Treatment focuses on treating the underlying infection with antibiotics and supporting respiratory function. Prevention involves good hygiene, vaccination against influenza, and not smoking.
This document discusses pneumonia in children. It defines pneumonia and describes different types including lobar, bronchopneumonia, and interstitial pneumonia. The pathogens causing pneumonia vary by a child's age. Clinical manifestations depend on age with neonates showing subtle signs and older children showing fever, cough, and difficulty breathing. Investigations may include blood tests, chest x-rays, and culture of respiratory samples. Treatment depends on severity but usually involves antibiotics, oxygen, and hospitalization for severe or complicated cases. World Health Organization guidelines recommend oral amoxicillin for non-severe cases and injectable antibiotics for severe or non-responding cases.
1) A 2-year-old male child, KW, was admitted with a 3-day history of cough but no difficulty breathing, fever, or other symptoms.
2) On examination, KW had an increased respiratory rate of 70 bpm and abnormal bloodwork. He was diagnosed with bronchopneumonia.
3) KW's treatment plan included intravenous ampicillin, gentamicin, and hydrocortisone for 5 days to treat the bronchopneumonia. By day 2, his symptoms had improved and he was continuing on the antibiotic treatment plan with the goal of discharging him on oral amoxicillin.
Approach to a child with respiratry tract infectionTushar Jagzape
This document discusses the approach to diagnosing and treating respiratory tract infections in children. It begins by listing the objectives and introducing that respiratory infections are common in children, with upper respiratory infections making up 40-50% of pediatric outpatient cases. It then describes the components of the respiratory tract, common symptoms, and appropriate examinations. The document emphasizes establishing if the infection is upper or lower respiratory, identifying causative organisms, and providing symptomatic relief with antibiotics reserved for specific bacterial infections.
Pharmacotherapy of Lower respiratory tract infectionsTsegaye Melaku
This document provides information on lower respiratory tract infections. It discusses the epidemiology, etiology, pathogenesis and management of common lower respiratory tract infections. It compares different lower respiratory tract infections based on their clinical presentations. It also classifies pneumonia based on microbiology and setting. The document outlines appropriate management strategies and treatment outcomes for lower respiratory tract infections. Host defenses of the respiratory tract and factors that can interfere with defenses are described. Common lower respiratory infections like pneumonia, bronchitis and bronchiolitis are also discussed.
This document discusses various types of chest infections including acute bronchitis, acute exacerbation of chronic bronchitis, and community acquired pneumonia. It outlines the typical bacteria that cause these infections and recommends antibiotics for treatment. For most cases of acute bronchitis and community acquired pneumonia in previously healthy individuals, amoxicillin is recommended. Erythromycin is suggested if an atypical infection like Mycoplasma pneumoniae is suspected. Antibiotic use should be limited to cases where symptoms meet specific criteria to reduce antibiotic resistance.
Bronchopneumonia is a type of pneumonia characterized by multiple areas of lung consolidation affecting one or more lobes. It is caused by viruses, bacteria, fungi or other pathogens and can develop as a complication of other illnesses like measles or influenza. Symptoms include fever, cough with mucus, chest pain, fatigue and decreased appetite. Diagnosis involves auscultation, chest x-ray, and laboratory tests. Treatment focuses on antibiotics, oxygen, rest, hydration and fever reduction. Nursing care involves airway clearance, infection control and addressing related issues like congestive heart failure.
This document provides a case study on a 3-month-old female patient (KNS) who was admitted to the hospital for fever, cough, and convulsion and was diagnosed with empyema secondary to pneumonia. It includes background information on pneumonia and empyema, signs and symptoms, diagnosis, treatment, and theories that guide the study. The rationale for the study is that respiratory disease is a leading cause of death in infants and it is important to understand the disease process and how it affects children.
Pneumonia is an acute lung infection that can be caused by bacteria, viruses, or other pathogens. It can be diagnosed based on clinical signs and symptoms as well as tests like chest x-rays. Severity is assessed using scoring systems like CURB-65 which evaluate factors like confusion, blood urea levels, respiratory rate, blood pressure, and age. Empiric antibiotic treatment for pneumonia depends on the likely causative organisms, which vary geographically, and the patient's characteristics and severity of illness. Tests are important for confirming diagnosis and guiding targeted therapy.
The document provides guidelines for collecting and transporting respiratory tract specimen for various infections, including proper labeling and storage. It describes common respiratory tract infections like pneumonia, their causes, symptoms, and treatment options. Pneumonia is classified as lobar, bronchopneumonia, or interstitial based on anatomical location and involvement; and as typical, atypical, community-acquired, or hospital-acquired based on etiology.
Pneumonia is an inflammation of the lung parenchyma caused by a microbial agent. It can be caused by bacteria, viruses, fungi or parasites. There are different classifications including community-acquired pneumonia (CAP), hospital-acquired pneumonia, and pneumonia in immunocompromised hosts. CAP is usually caused by Streptococcus pneumoniae or Haemophilus influenzae. Hospital-acquired pneumonia has a higher risk of drug-resistant organisms. Clinical manifestations include fever, cough, shortness of breath and chest pain.
This document discusses lower respiratory tract infections (LRTIs), specifically pneumonia. It defines community-acquired pneumonia (CAP), healthcare-associated pneumonia (HCAP), and hospital-acquired pneumonia (HAP) and lists risk factors. Pathophysiology involves impairment of respiratory defenses allowing pathogens to reach the lungs. Pneumonia signs include fever, cough, and chest exam findings. Goals of therapy are eradicating the pathogen and clinical cure. Treatment options include oxygen, bronchodilators, antibiotics, and referral depending on location and suspected pathogen. Empiric antibiotic therapy depends on clinical setting and risk factors for multidrug-resistant organisms.
This document provides information on evaluating and diagnosing children with recurrent pneumonia. It discusses obtaining a thorough medical history including details of pneumonia episodes, risk factors, and associated symptoms. A complete physical exam focuses on the respiratory system and signs of underlying conditions. Initial tests include a CBC, chest X-ray, and Mantoux test. Further tests like CT, PFTs, bronchoscopy may help identify structural abnormalities, aspiration, or immunodeficiencies causing recurrent pneumonia. Treatment involves managing the specific illness and providing nutritional/respiratory support.
Bronchopneumonia is a leading cause of death in children worldwide, accounting for 15% of pediatric deaths. It is an inflammatory process involving the lung parenchyma with consolidation of the lung tissue. Incidence is highest in infants and young children, with 90% of respiratory deaths due to pneumonia. Clinical features include cough, fever, respiratory distress, and signs vary by age and severity. Treatment involves antibiotics, oxygen, IV fluids, and supportive care. Complications can include empyema, abscess, and effusion. Nursing care focuses on airway clearance, maintaining oxygenation and hydration, pain management, and educating parents to relieve anxiety.
PneumoniaCheck, the link between the diagnosis and treatment of pneumonia wit...Steve Koontz
This document discusses the need for an improved method of diagnosing pneumonia. Current methods often cannot identify the specific pathogen causing pneumonia, resulting in overuse of broad-spectrum antibiotics and increased antibiotic resistance. It introduces PneumoniaCheck, a new device that uses fluid mechanics to separate upper airway particles from lower airway particles collected from a patient's cough, allowing identification of the pathogen. This more targeted approach can reduce unnecessary antibiotic use and complications by precisely diagnosing the type of pneumonia.
Pneumonia is a major cause of death among children under 5 years old globally. It accounts for 16% of under-5 mortality. The incidence of pneumonia in under-5 children is 0.22 episodes per child per year, with 11.5% progressing to severe episodes. Bacterial and viral pathogens are common causes. Clinical presentation, imaging and laboratory findings can help distinguish between bacterial and viral pneumonia. Appropriate treatment includes antibiotics, supportive care and prevention strategies like breastfeeding, immunization, nutrition and hygiene.
This document provides information about pneumonia, including epidemiology, common causes, diagnosis, treatment, and prevention. It notes that pneumonia affects over 3 million people annually in the US, with higher rates in winter and among males and those over 65. Diagnosis involves clinical assessment of symptoms and signs, with chest x-ray and testing to confirm. Treatment depends on location of acquisition and risk factors, starting with broad-spectrum antibiotics and later targeting likely pathogens. Prevention focuses on vaccination, especially for influenza and pneumococcus, and reducing risk factors like smoking.
Pneumonia is an infection of the lower respiratory tract that involves the airways and lung tissue. It can be caused by viruses, bacteria, or other pathogens. Symptoms may include fever, cough, difficulty breathing, and chest pain. Treatment involves supportive care and antibiotics depending on the suspected cause and severity of illness. Chest x-rays are sometimes needed to identify the location and extent of lung involvement and check for complications.
This document reviews pulmonary diseases including COPD, asthma, and tuberculosis. It describes COPD as consisting of chronic bronchitis and emphysema, both causing difficulty exhaling air. Asthma is defined as a chronic inflammatory lung disease causing recurrent breathing issues. Tuberculosis is caused by the Mycobacterium tuberculosis bacteria, which primarily attacks the lungs. It can spread through airborne droplets when coughing or sneezing. The document outlines symptoms, diagnostic tests, and treatments for each disease.
This document discusses various respiratory diagnoses and provides details on their symptoms, signs, etiology, diagnosis, and treatment. It covers upper respiratory infections like acute rhinitis, allergic rhinitis, acute sinusitis, acute pharyngitis, acute tonsillitis, and acute laryngitis. It also discusses lower respiratory infections such as acute bronchitis, chronic bronchitis, COPD, bronchial asthma, lobar pneumonia, bronchopneumonia, and interstitial pneumonia. Other conditions covered include acute viral pleurisy, pleural effusions, pneumothorax, tuberculosis, and lung cancers. For each diagnosis, it lists relevant symptoms, physical exam findings, cause, investigations needed and recommended treatment approaches
Through this SlideShare you can understand about Pneumonia..
How it occurr, what are the etiology, how many types are there , what is the medicine for this disease conditions, how to recover from this disease conditions and how to prevent all this things...
If it is helpful then please like and share others and help others to get knowledge about this disease conditions ( Pneumonia ).
This document summarizes information on allergic rhinitis and sinusitis. It discusses the pathophysiology, symptoms, diagnosis and management of allergic rhinitis. Intranasal corticosteroids are identified as the most effective treatment. It also covers the diagnosis and treatment of acute and chronic sinusitis, including complications. Imaging such as CT is recommended for complicated cases or recurrent sinusitis.
Allergic rhinitis is a chronic inflammatory disease of the nasal passages affecting over 20% of the population. It is characterized by sneezing, nasal congestion, rhinorrhea, and itching caused by an immune response to allergens such as pollen, dust mites, and animal dander. Treatment involves identifying and avoiding triggers, using intranasal corticosteroids as first line therapy to reduce inflammation, and oral antihistamines to relieve symptoms. Immunotherapy may be used for severe, treatment-resistant cases.
Approach to a child with respiratry tract infectionTushar Jagzape
This document discusses the approach to diagnosing and treating respiratory tract infections in children. It begins by listing the objectives and introducing that respiratory infections are common in children, with upper respiratory infections making up 40-50% of pediatric outpatient cases. It then describes the components of the respiratory tract, common symptoms, and appropriate examinations. The document emphasizes establishing if the infection is upper or lower respiratory, identifying causative organisms, and providing symptomatic relief with antibiotics reserved for specific bacterial infections.
Pharmacotherapy of Lower respiratory tract infectionsTsegaye Melaku
This document provides information on lower respiratory tract infections. It discusses the epidemiology, etiology, pathogenesis and management of common lower respiratory tract infections. It compares different lower respiratory tract infections based on their clinical presentations. It also classifies pneumonia based on microbiology and setting. The document outlines appropriate management strategies and treatment outcomes for lower respiratory tract infections. Host defenses of the respiratory tract and factors that can interfere with defenses are described. Common lower respiratory infections like pneumonia, bronchitis and bronchiolitis are also discussed.
This document discusses various types of chest infections including acute bronchitis, acute exacerbation of chronic bronchitis, and community acquired pneumonia. It outlines the typical bacteria that cause these infections and recommends antibiotics for treatment. For most cases of acute bronchitis and community acquired pneumonia in previously healthy individuals, amoxicillin is recommended. Erythromycin is suggested if an atypical infection like Mycoplasma pneumoniae is suspected. Antibiotic use should be limited to cases where symptoms meet specific criteria to reduce antibiotic resistance.
Bronchopneumonia is a type of pneumonia characterized by multiple areas of lung consolidation affecting one or more lobes. It is caused by viruses, bacteria, fungi or other pathogens and can develop as a complication of other illnesses like measles or influenza. Symptoms include fever, cough with mucus, chest pain, fatigue and decreased appetite. Diagnosis involves auscultation, chest x-ray, and laboratory tests. Treatment focuses on antibiotics, oxygen, rest, hydration and fever reduction. Nursing care involves airway clearance, infection control and addressing related issues like congestive heart failure.
This document provides a case study on a 3-month-old female patient (KNS) who was admitted to the hospital for fever, cough, and convulsion and was diagnosed with empyema secondary to pneumonia. It includes background information on pneumonia and empyema, signs and symptoms, diagnosis, treatment, and theories that guide the study. The rationale for the study is that respiratory disease is a leading cause of death in infants and it is important to understand the disease process and how it affects children.
Pneumonia is an acute lung infection that can be caused by bacteria, viruses, or other pathogens. It can be diagnosed based on clinical signs and symptoms as well as tests like chest x-rays. Severity is assessed using scoring systems like CURB-65 which evaluate factors like confusion, blood urea levels, respiratory rate, blood pressure, and age. Empiric antibiotic treatment for pneumonia depends on the likely causative organisms, which vary geographically, and the patient's characteristics and severity of illness. Tests are important for confirming diagnosis and guiding targeted therapy.
The document provides guidelines for collecting and transporting respiratory tract specimen for various infections, including proper labeling and storage. It describes common respiratory tract infections like pneumonia, their causes, symptoms, and treatment options. Pneumonia is classified as lobar, bronchopneumonia, or interstitial based on anatomical location and involvement; and as typical, atypical, community-acquired, or hospital-acquired based on etiology.
Pneumonia is an inflammation of the lung parenchyma caused by a microbial agent. It can be caused by bacteria, viruses, fungi or parasites. There are different classifications including community-acquired pneumonia (CAP), hospital-acquired pneumonia, and pneumonia in immunocompromised hosts. CAP is usually caused by Streptococcus pneumoniae or Haemophilus influenzae. Hospital-acquired pneumonia has a higher risk of drug-resistant organisms. Clinical manifestations include fever, cough, shortness of breath and chest pain.
This document discusses lower respiratory tract infections (LRTIs), specifically pneumonia. It defines community-acquired pneumonia (CAP), healthcare-associated pneumonia (HCAP), and hospital-acquired pneumonia (HAP) and lists risk factors. Pathophysiology involves impairment of respiratory defenses allowing pathogens to reach the lungs. Pneumonia signs include fever, cough, and chest exam findings. Goals of therapy are eradicating the pathogen and clinical cure. Treatment options include oxygen, bronchodilators, antibiotics, and referral depending on location and suspected pathogen. Empiric antibiotic therapy depends on clinical setting and risk factors for multidrug-resistant organisms.
This document provides information on evaluating and diagnosing children with recurrent pneumonia. It discusses obtaining a thorough medical history including details of pneumonia episodes, risk factors, and associated symptoms. A complete physical exam focuses on the respiratory system and signs of underlying conditions. Initial tests include a CBC, chest X-ray, and Mantoux test. Further tests like CT, PFTs, bronchoscopy may help identify structural abnormalities, aspiration, or immunodeficiencies causing recurrent pneumonia. Treatment involves managing the specific illness and providing nutritional/respiratory support.
Bronchopneumonia is a leading cause of death in children worldwide, accounting for 15% of pediatric deaths. It is an inflammatory process involving the lung parenchyma with consolidation of the lung tissue. Incidence is highest in infants and young children, with 90% of respiratory deaths due to pneumonia. Clinical features include cough, fever, respiratory distress, and signs vary by age and severity. Treatment involves antibiotics, oxygen, IV fluids, and supportive care. Complications can include empyema, abscess, and effusion. Nursing care focuses on airway clearance, maintaining oxygenation and hydration, pain management, and educating parents to relieve anxiety.
PneumoniaCheck, the link between the diagnosis and treatment of pneumonia wit...Steve Koontz
This document discusses the need for an improved method of diagnosing pneumonia. Current methods often cannot identify the specific pathogen causing pneumonia, resulting in overuse of broad-spectrum antibiotics and increased antibiotic resistance. It introduces PneumoniaCheck, a new device that uses fluid mechanics to separate upper airway particles from lower airway particles collected from a patient's cough, allowing identification of the pathogen. This more targeted approach can reduce unnecessary antibiotic use and complications by precisely diagnosing the type of pneumonia.
Pneumonia is a major cause of death among children under 5 years old globally. It accounts for 16% of under-5 mortality. The incidence of pneumonia in under-5 children is 0.22 episodes per child per year, with 11.5% progressing to severe episodes. Bacterial and viral pathogens are common causes. Clinical presentation, imaging and laboratory findings can help distinguish between bacterial and viral pneumonia. Appropriate treatment includes antibiotics, supportive care and prevention strategies like breastfeeding, immunization, nutrition and hygiene.
This document provides information about pneumonia, including epidemiology, common causes, diagnosis, treatment, and prevention. It notes that pneumonia affects over 3 million people annually in the US, with higher rates in winter and among males and those over 65. Diagnosis involves clinical assessment of symptoms and signs, with chest x-ray and testing to confirm. Treatment depends on location of acquisition and risk factors, starting with broad-spectrum antibiotics and later targeting likely pathogens. Prevention focuses on vaccination, especially for influenza and pneumococcus, and reducing risk factors like smoking.
Pneumonia is an infection of the lower respiratory tract that involves the airways and lung tissue. It can be caused by viruses, bacteria, or other pathogens. Symptoms may include fever, cough, difficulty breathing, and chest pain. Treatment involves supportive care and antibiotics depending on the suspected cause and severity of illness. Chest x-rays are sometimes needed to identify the location and extent of lung involvement and check for complications.
This document reviews pulmonary diseases including COPD, asthma, and tuberculosis. It describes COPD as consisting of chronic bronchitis and emphysema, both causing difficulty exhaling air. Asthma is defined as a chronic inflammatory lung disease causing recurrent breathing issues. Tuberculosis is caused by the Mycobacterium tuberculosis bacteria, which primarily attacks the lungs. It can spread through airborne droplets when coughing or sneezing. The document outlines symptoms, diagnostic tests, and treatments for each disease.
This document discusses various respiratory diagnoses and provides details on their symptoms, signs, etiology, diagnosis, and treatment. It covers upper respiratory infections like acute rhinitis, allergic rhinitis, acute sinusitis, acute pharyngitis, acute tonsillitis, and acute laryngitis. It also discusses lower respiratory infections such as acute bronchitis, chronic bronchitis, COPD, bronchial asthma, lobar pneumonia, bronchopneumonia, and interstitial pneumonia. Other conditions covered include acute viral pleurisy, pleural effusions, pneumothorax, tuberculosis, and lung cancers. For each diagnosis, it lists relevant symptoms, physical exam findings, cause, investigations needed and recommended treatment approaches
Through this SlideShare you can understand about Pneumonia..
How it occurr, what are the etiology, how many types are there , what is the medicine for this disease conditions, how to recover from this disease conditions and how to prevent all this things...
If it is helpful then please like and share others and help others to get knowledge about this disease conditions ( Pneumonia ).
This document summarizes information on allergic rhinitis and sinusitis. It discusses the pathophysiology, symptoms, diagnosis and management of allergic rhinitis. Intranasal corticosteroids are identified as the most effective treatment. It also covers the diagnosis and treatment of acute and chronic sinusitis, including complications. Imaging such as CT is recommended for complicated cases or recurrent sinusitis.
Allergic rhinitis is a chronic inflammatory disease of the nasal passages affecting over 20% of the population. It is characterized by sneezing, nasal congestion, rhinorrhea, and itching caused by an immune response to allergens such as pollen, dust mites, and animal dander. Treatment involves identifying and avoiding triggers, using intranasal corticosteroids as first line therapy to reduce inflammation, and oral antihistamines to relieve symptoms. Immunotherapy may be used for severe, treatment-resistant cases.
The document discusses various diseases of the nose and ear, including their causes, symptoms, and treatment options. It covers common colds, influenza, allergic rhinitis, sinusitis, otitis externa, otitis media, and more. For treatment, it recommends medications like antihistamines, decongestants, steroids, antibiotics, and provides dosage information. Prevention methods are also outlined, such as allergen avoidance and regular ear cleaning.
This document provides an overview of upper respiratory tract infections including classification, common diseases, symptoms, diagnosis, and treatment. Upper respiratory tract infections involve the areas above the vocal cords such as the nose, sinuses, throat, and voice box. Common illnesses discussed are the common cold, acute rhinosinusitis, pharyngitis, and acute otitis media. The document outlines symptoms, causative agents, diagnostic approaches, and antibiotic treatment recommendations for each condition.
Allergic rhinitis is an inflammation of the nasal passages caused by an immune response to common allergens like pollen, dust mites, or animal dander. It affects about 1 in 5 people in the UK and causes symptoms like sneezing, nasal congestion, and watery eyes. While it is usually diagnosed based on symptoms, skin or blood tests can help identify specific allergens. Treatment involves avoidance of triggers, oral antihistamines, intranasal corticosteroids, and immunotherapy for severe cases. Referral to an ENT specialist is recommended if symptoms persist despite treatment or if red flags for other conditions are present.
This document provides information on allergic rhinitis (AR), including its pathophysiology, classification, clinical presentation, diagnosis, and management. Some key points:
- AR results from an IgE-mediated inflammatory response in the nasal mucosa triggered by allergens. It causes symptoms like sneezing, rhinorrhea, and nasal congestion.
- It affects 10-20% of the population and is classified based on duration (intermittent vs persistent) and severity (mild, moderate, severe).
- A family history of allergies or asthma increases risk. Patients often have concurrent conditions like asthma, conjunctivitis.
- Treatment involves avoidance of triggers,
The document discusses allergic rhinitis, also known as hay fever. It provides statistics on the prevalence and burden of allergic rhinitis in the United States. It also outlines the causes, diagnosis, and treatment options for allergic rhinitis including avoidance strategies, medications, immunotherapy, and more.
The document outlines terms of use for an educational slide set on acute sinusitis. It specifies that the slides remain the copyrighted property of the American College of Physicians and may only be used for nonprofit educational activities. Users can incorporate slides into their own presentations but may not alter the content or remove the copyright notice. Print copies can be made for handouts but broader reproduction or distribution requires permission. Unauthorized use constitutes copyright infringement.
Rhinitis is inflammation of the nasal cavity that can be allergic or non-allergic in nature. Allergic rhinitis, also known as hay fever, is caused by an allergen triggering an immune response. Non-allergic rhinitis includes acute viral/bacterial rhinitis from infections as well as chronic rhinitis from long-term irritation or obstruction. Symptoms include sneezing, congestion, and rhinorrhea. Treatment focuses on environmental control, medications like antihistamines, nasal steroids, and immunotherapy for allergies. Chronic rhinitis can lead to sinusitis if mucus is unable to drain properly from the sinuses.
- Allergic rhinitis is a chronic inflammation of the nasal mucous membrane caused by exposure to allergens like pollen, dust mites, and mold. It is more common in children and often runs in families.
- Symptoms include repetitive sneezing, nasal congestion, runny nose, postnasal drip, cough, and irritation. Allergic rhinitis is classified as seasonal or perennial depending on symptom duration.
- Management involves avoidance of triggers, patient education, and drug treatment including antihistamines, nasal decongestants, mast cell stabilizers, topical corticosteroids, and sometimes oral corticosteroids. The goal is symptomatic relief and prevention
Allergic Rhinitis is an inflammatory disorder of the nasal mucosa caused by an IgE-mediated response to allergens. It is characterized by symptoms like sneezing, rhinorrhea, nasal congestion and pruritus. Onset is often in childhood or adolescence. While symptoms may improve with age, allergic rhinitis can develop or persist at any age. It is associated with conditions like asthma, sinusitis and otitis media. Management involves allergen avoidance, pharmacotherapy and immunotherapy. Second generation antihistamines are first line treatment but adding a leukotriene receptor antagonist provides additional relief, especially for nasal congestion. Intranasal corticosteroids are also
Allergic Rhinitis is an inflammatory disorder of the nasal mucosa caused by an IgE-mediated response to allergens. It is characterized by symptoms like sneezing, rhinorrhea, nasal congestion and pruritus. Allergic Rhinitis can negatively impact quality of life and productivity. It commonly begins in childhood or adolescence. While symptoms often improve with age, the disorder can develop or persist at any age. Treatment involves allergen avoidance, pharmacotherapy including antihistamines, intranasal corticosteroids and leukotriene inhibitors, as well as immunotherapy. Combination therapy with a second-generation antihistamine and montelukast has been shown to more effectively treat
The document discusses various respiratory disorders and their dental management considerations. It provides information on common respiratory conditions like sinusitis, nasal polyps, obstructive sleep apnea, allergic rhinitis, tonsillitis, pharyngitis, laryngitis, influenza, post nasal drip syndrome, chronic obstructive pulmonary disease, bronchitis, asthma, emphysema and pneumonia. It outlines the symptoms, causes, diagnosis and treatment for these conditions. It emphasizes the importance of thorough medical history taking and providing treatment with precautions based on a patient's respiratory condition.
The document discusses upper respiratory tract disorders such as rhinitis and sinusitis. It defines rhinitis as inflammation of the nasal mucosa which can be caused by allergies, infections, or irritants. The pathophysiology of allergic rhinitis involves IgE antibodies binding to mast cells and triggering an inflammatory response. Sinusitis occurs when sinus openings are blocked, allowing bacteria to grow. Common symptoms include facial pain and pressure, nasal congestion, and headache. Medical management of sinusitis focuses on antibiotics to treat the infection and relieve symptoms.
This document discusses allergic rhinitis, including its definition, symptoms, classification, risk factors, and management approaches. It defines allergic rhinitis as an IgE-mediated inflammatory disorder of the nasal mucosa induced by allergen exposure. Symptoms include sneezing, rhinorrhea, nasal congestion, and pruritus. Treatment involves allergen avoidance, pharmacotherapy including antihistamines, intranasal corticosteroids, leukotriene modifiers, and immunotherapy. The combination of antihistamines and leukotriene modifiers is more effective for moderate-severe symptoms than monotherapy. Intranasal corticosteroids are also effective but a chronic treatment approach is needed.
This document discusses atopy, allergic rhinitis, and asthma. It defines atopy as a genetic predisposition to develop IgE-mediated hypersensitivity responses upon exposure to allergens. Allergic rhinitis, or hay fever, is an inflammatory disease of the nasal passages caused by an allergic reaction to airborne allergens like pollen and dust mites. Common symptoms include sneezing, stuffy nose, and runny nose. Asthma is a chronic inflammatory lung disease characterized by reversible airway obstruction, airway inflammation, and hyperresponsiveness to stimuli.
Pharmacotherapy of Upper respiratory tract infectionsTsegaye Melaku
This document provides information on upper respiratory tract infections (URTIs) with a focus on otitis media. It discusses the common bacterial causes of otitis media, including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It also outlines the signs and symptoms of acute otitis media, including ear pain, fever, and bulging of the eardrum. The document recommends amoxicillin as the first-line treatment and discusses alternative antibiotic options if needed. It emphasizes the importance of differentiating between acute otitis media and otitis media with effusion to determine appropriate treatment.
This document provides information on diagnosing and managing hypochondriasis and delirium. It discusses:
- The diagnostic criteria for hypochondriasis including preoccupation with health despite medical evaluations finding no evidence of disease.
- Hypochondriasis is often associated with panic disorder and major depressive disorder.
- Differential diagnoses for hypochondriasis including physical illness, depression, panic disorder, OCD, and psychotic disorders.
- Treatment for hypochondriasis involves cognitive behavioral therapy and antidepressants for comorbid conditions.
- Delirium risk factors include older age, cognitive impairment, medications, infection and environmental changes. Screening tools like the Confusion Assessment
This document discusses various preventive medicine topics including vaccines for MMR, influenza, meningococcal disease, pneumococcal disease, hepatitis A, hepatitis B, polio, and varicella. It provides information on indications, contraindications, dosing schedules, and evidence of immunity for each vaccine. Recommendations are given for vaccinating special populations including HIV patients, the elderly, those with chronic illnesses, international travelers, and health care workers.
The document discusses various pediatric topics including common conditions like conjunctivitis, jaundice, and orthopedic disorders. It also covers neonatal topics such as neonatal conjunctivitis, causes like chemical, HSV, gonorrheal, and chlamydia conjunctivitis. Normal vital signs for children of different ages are also presented.
This document provides guidelines for various cancer screening tests including mammography, pap smear, colonoscopy, and flexible sigmoidoscopy. It outlines the starting age, frequency, and ending age for each test. A case study is presented regarding a 66 year old woman found to have a breast mass. Screening protocols and efficacy for colonoscopy in detecting colon cancer are discussed. Risk factors, staging, and treatments for colon and breast cancer are also summarized.
Menopause is defined as amenorrhea for at least one year associated with elevated FSH levels. Common symptoms include hot flashes, night sweats, mood changes, and vaginal dryness. It is important to evaluate for signs of osteoporosis like height loss or kyphosis on exam. Differential diagnoses include premature ovarian failure, thyroid disorders, autoimmune disorders, and hyperprolactinemia. An elevated FSH level is consistent with menopause. Hormone replacement therapy can effectively treat vasomotor symptoms but is associated with increased risks of venous thromboembolism, breast cancer, and cardiovascular disease. Non-hormonal options and lifestyle modifications should be discussed.
This document discusses risk factors and management of various types of stroke. It identifies several risk factors for stroke including age over 50, hypertension, diabetes, hyperlipidemia, smoking, and atrial fibrillation. Primary prevention strategies include controlling hypertension and diabetes, smoking cessation, and anticoagulation for atrial fibrillation. Acute ischemic stroke is initially evaluated with CT head to rule out hemorrhage, and may be treated with thrombolytics if indicated. Secondary prevention involves lifestyle modifications and long-term antithrombotic therapy.
This document provides an overview of renal failure, including:
- The differences between acute and chronic renal failure. Acute renal failure can be pre-renal, renal, or post-renal and have various causes including glomerular, tubular, or interstitial disease.
- Evaluation of renal function includes urinalysis, urine indices, imaging studies, and other tests.
- Causes, management, and indications for dialysis in acute renal failure. Chronic tubulointerstitial diseases can have various toxic, infectious, immunologic, metabolic, hereditary, or vascular causes.
- Definitions and evaluation of proteinuria, acute tubular necrosis, renal biopsy procedures, and glomerular
The document discusses the diagnosis of syphilis through various testing methods. Dark field microscopy can detect Treponema pallidum in lesions during primary or secondary syphilis. Non-treponemal tests like VDRL and RPR are screening tests but have low sensitivity in early and late syphilis. Treponemal specific tests like FTA-Abs are used to confirm syphilis diagnosis when non-treponemal tests are reactive. Both types of tests are used at different stages of syphilis to make or confirm the diagnosis.
Idiopathic DVT refers to a DVT case where there is no obvious underlying cause such as recent surgery, trauma or known malignancy identified. About 30-40% of DVT cases are considered idiopathic. Evaluation should aim to rule out occult cancer or inherited or acquired thrombophilia. Treatment is the same as DVT with known risk factors.
1) An 82-year-old man with a history of COPD, hypertension, and colon cancer presented with increasing shortness of breath and right-sided chest pain.
2) CT imaging showed a new 2.3cm spiculated nodule in the right upper lobe of the lung. PET/CT revealed increased uptake in the nodule and lymph nodes, concerning for malignancy.
3) The patient underwent navigational bronchoscopy and biopsy of the lung nodule. Pathology revealed sarcomatoid carcinoma, a rare, very aggressive form of non-small cell lung cancer associated with poor survival.
This document provides information on evaluating and diagnosing dyspepsia. It lists the most common causes of dyspepsia as functional or non-ulcer dyspepsia. Other potential causes discussed include peptic ulcer disease, GERD, biliary tract disease, pancreatitis, cancer, IBS, and various metabolic disorders and medications. It provides questions to ask patients to determine the underlying cause, such as symptoms, medical history, risk factors. Common drugs associated with dyspepsia are also listed. Diagnosis involves considering the differential, patient history, and potentially endoscopy, urea breath testing, and other studies.
- Physicians must maintain patient confidentiality but may break it if the patient poses a threat to themselves or others, or if required by law such as with infectious diseases. Efforts should be made to discuss issues with the patient first.
- Informed consent is required to share a patient's medical information with others or to perform medical procedures. Exceptions include emergencies or if the patient lacks capacity.
- Decisions about withholding or withdrawing care should be made based on the patient's wishes if known, or their best interests if not. Surrogate decision makers may be consulted for incompetent patients.
A 58-year-old woman presents with symptoms of hyperthyroidism including anxiety, tremors, sweating, palpitations and insomnia. On exam she has a modest, non-tender goiter. Thyroid function tests show a suppressed TSH and elevated free T4, consistent with primary hyperthyroidism. A thyroid uptake scan shows diffuse homogeneous uptake, consistent with Graves' disease. She is started on methimizole to treat her hyperthyroidism due to Graves' disease.
This document provides information on various dermatological conditions including:
- Pityriasis versicolor, its symptoms, diagnosis via KOH mount, and treatment with selenium sulfide or oral antifungals.
- Acne types and treatments including topical retinoids, antibiotics, isotretinoin, and avoiding exacerbating factors.
- Rosacea symptoms like flushing and papules and treatments like metronidazole gel, doxycycline, and lifestyle changes.
- Alopecia areata causes, presentations as patches of hair loss, and treatments like intralesional steroids or contact sensitizers.
- Information on topical corticosteroid potency and adverse
This document provides information on various rheumatological conditions including osteoarthritis, gout, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, Sjogren's syndrome, and polymyalgia rheumatica. It describes the diagnostic criteria, clinical features, organ involvement, treatment recommendations, and important complications for each condition. Key points include the importance of Heberden's and Bouchard's nodes in diagnosing osteoarthritis, using allopurinol to treat gout and prevent attacks, methotrexate and TNF inhibitors for treating rheumatoid arthritis, and aggressive treatment of lupus nephritis to prevent morbidity.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Are you looking for a long-lasting solution to your missing tooth?
Dental implants are the most common type of method for replacing the missing tooth. Unlike dentures or bridges, implants are surgically placed in the jawbone. In layman’s terms, a dental implant is similar to the natural root of the tooth. It offers a stable foundation for the artificial tooth giving it the look, feel, and function similar to the natural tooth.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Breast cancer: Post menopausal endocrine therapyDr. Sumit KUMAR
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
How to Control Your Asthma Tips by gokuldas hospital.Gokuldas Hospital
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Pictorial and detailed description of patellar instability with sign and symptoms and how to diagnose , what investigations you should go with and how to approach with treatment options . I have presented this slide in my 2nd year junior residency in orthopedics at LLRM medical college Meerut and got good reviews for it
After getting it read you will definitely understand the topic.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
“Psychiatry and the Humanities”: An Innovative Course at the University of Mo...Université de Montréal
“Psychiatry and the Humanities”: An Innovative Course at the University of Montreal Expanding the medical model to embrace the humanities. Link: https://www.psychiatrictimes.com/view/-psychiatry-and-the-humanities-an-innovative-course-at-the-university-of-montreal
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
3.
Allergic Rhinitis
Hay fever
Onset under age 30
Peak incidence – childhood & adolescence
Most common chronic disease in the USA and significantly
affects quality of life
Pathophysiology : Type I hypersensitivity reaction to
allergens
Common allergens : Seasonal Allergens: Tree pollen (early
spring), Grass pollen (late spring) and Outdoor Molds (summer
and fall) ) , Perennial : Dust mites and Animal dander Irritant:
Cigarette Smoke
Associated conditions : Atopy : Eczematous Dermatitis ,
Allergic Rhinitis and Asthma
Allergic Triad : Aspirin Allergy, Nasal
Polyp and Asthma
4. Allergic Rhinitis
Symptoms:
Specific : Sneezing, Rhinorrhea, Nasal congestion and Pruritus of the
nose, eyes, and throat , Eye Tearing and Conjunctival discharge
Symptoms due to Chronic Nasal Obstruction: Mouth Breathing,
Snoring, Anosmia, Cough, Headache and Halitosis
Signs : * Look for antihistamine induced Hypertension in these guys
*Nose exam : pale blue and boggy mucosa, clear discharge
*Face exam: “Allergic Shiners” bluish purple rings arround both
eyes due to chronic mid face venos congestion
“ Dennie’s Lines: Skin folds under the eyes
“ Allergic Salute: transverse nasal crease from
chronic rubbing
*Sinuses: r/o sinusitis purulent discharge, tenderness and
impaired transillumination
5. Allergic Rhinitis
Diagnosis : * Skin testing Gold Standard
* RAST
use this if unable to do a skin test or if its
contraindicated
* CBC may show eosinophilia
* IgE levels are elevated
D/D : 1) Nasal causes of Rhinitis : Nonallergic rhinitis ( eosinophila
synd), Nasal polyps, Vasomotor rhinitis, infectious rhinitis, Rhinitis
medicamentosa
2) Medications: Aspirin, Clonidine, Hydralazine, Labetalol,
propranolol, tearazosin, OC pills
Management Do Skin test / RAST and find the responsible
Allergen. Advise the pt to avoid the allergen. “Avoid pets in the bed if
its found to be animal dander”
Intranasal Steroids ( are the drug of choice for pts
with chronic symptoms. Can be used prn but most effective when
used as maintainance therapy fluticasone, beclomethasone) ,
Antihistamines ( cetrizine, loratidine) , Saline nasal drops ,
decongestants ( pseudoephedrine), nasal cromolyn
6. Allergic Rhinitis
Antihistamines vs. Nasal Corticosteroids. The majority of
studies favor the use of intranasal corticosteroids over
sedating or nonsedating antihistamines for relief of
symptoms of nasal allergy. These results are true for
seasonal and perennial allergic rhinitis. ( antihistamines are
used for immediate symptom relief)
Immunotherapy: Immunotherapy is indicated in patients who
present with any of the following characteristics:
Insufficient control by pharmacotherapy;
Insufficient control of symptoms;
A desire not to take medication;
Medication produces undesirable side effects; and
A desire to avoid long-term pharmacotherapy (with
intranasal steroids)
7. Case Study
You are treating an 18-year-old white male college
freshman for allergic rhinitis. It is September and he
tells you that he has severe symptoms every autumn,
which impair his academic performance. He has a
strongly positive family history of atopic dermatitis.
Which one of the following medication is
considered optimal treatment for this condition?
Intranasal glucocorticoids
Intranasal cromolym sodium
Intranasal decongestants
Intranasal antihistamine
8. Ans
Topical intranasal glucocorticoids are currently believed to be the most efficacious
medications for the treatment of allergic rhinitis. They are far superior to oral
preparations in terms of safety.
Cromolyn sodium is also an effective topical agent for allergic rhinitis; however, it
is more effective if started prior to the season of peak symptoms.
Because of the high risk of rhinitis medicamentosa with chronic use of topical
decongestants, these agents have limited usefulness in the treatment of allergic
rhinitis.
Some of the newer oral antihistamines have been found to be comparable in
efficacy to intranasal steroids, but their use slightly increases the incidence of
adverse effects and drug interactions. They are not as useful for congestion as they
are for sneezing, pruritis, and rhinorrhea. Newer agents are relatively free of
sedation. Overall, they are not as effective as topical glucocorticoids. Azelastine ,
an intranasal antihistamine, is effective in controlling symptoms but can cause
somnolence and has a very bitter taste.
9. Vasomotor Rhinitis
Diagnosis of exclusion
Symptoms similar as Allergic Rhinitis has rhinorrhea, congestion, nasal
obstruction ( normal nasal exam, normal Ig E and Normal skin test/
RAST )
No specific test is available to diagnose vasomotor rhinitis First
exclude allergic rhinitis as the cause of symptoms by using conventional
skin testing or by evaluation for specific IgE antibodies to known
allergens.
Rx: Stepwise Approach ( next slide )
Pregnancy
Step 1: Nasal Saline
Step 2: Intranasal Atrovent (Pregnancy Category B)
Traditional oral antihistamines have no established beneficial effect in patients
with vasomotor rhinitis and may be associated with sedation.
Newer, less-sedating antihistamines also have no proven effectiveness for
vasomotor rhinitis, and their administration delays proper treatment while
incurring significant cost and burden to the health care system. Topical
antihistamines are used as first choice if symps are rhinorrhea, sneezing,
post nasal drip
10.
11. Rhinitis Medicamentosa
Pathophysiology
Associated with topical agent use >5-7 days
Tachyphylaxis associated with medications
Nasal Decongestants (Afrin, Neo-Synephrine)
Other associated medications
Reserpine
Oral Contraceptive pills
Inderal
Aldomet
Symptoms
Rebound nasal Congestion after nasal Decongestant
Signs
Fiery red edema at nasal mucosa
Management
Intranasal Steroid
Withdrawal of nasal Decongestant
12. Acute & Chronic Sinusitis
Criteria for diagnosis:
Maxillary toothache
Purulent nasal secretion
History of colored Nasal discharge
Poor response to nasal Decongestants
Abnormal Sinus Transillumination
If 4 or more criteria + diagnosis is definite
If 2 or 3 crieria + Diagnosis is intermediate recommended initial study Sinus CT
If less than 2 criteria negative for sinusitis
Most common is maxillary sinusitis. Next common is Frontal. Ethmoids are most
commonly affected in children. Spenoids has highest risk of intracranial spread
Symptoms may last as long as 4 weeks in acute sinusitis, Symptoms b/w 4-8 weeks is
subacute ans symptoms persisting > 8 weeks is chronic sinusitis.
In recurrent sinusitis, there are 3 or more episodes of acute sinusitis per year, and
different episodes may be caused by different organisms.
Signs
Diagnostic tests
Step wise Treatment
Complications
13. Acute & Chronic Sinusitis
Signs :
Nasal Mucosa erythema and boggy due to edema
Contrast with Allergic Rhinitis (pale, boggy mucosa)
Nasal exam to view pus discharge from lateral wall
Instruments Nasal speculum (minimal visualization) , Flexible
Nasolaryngoscopy
Middle Meatus (hiatus semilunaris) Drains Maxillary, Frontal, and
Anterior Ethmoid Consider local Topical Decongestant application
Superior Meatus (Rarely discharge is seen) Drains posterior ethmoid
sinus
Turbinates enlarged
Sinus tenderness to percussion
Sinus Transillumination in darkened room
Frontal and maxillary sinus
14. Acute & Chronic Sinusitis
Symptoms suggesting bacterial etiology
Symptoms persist beyond 10 to 14 days,
Remember that under 10 days, viral sinusitis
predominates, By day 10, 40% of sinusitis
resolves spontaneously 0.5% of viral URIs
develop into bacterial sinusitis
Symptoms worsen after 5-7 days ( “double”
sickening)
purulent nasal discharge
“Unilateral” maxillary sinus tenderness
Maxillary tooth or facial pain (esp. if unilateral)
15. Acute & Chronic Sinusitis
Don’t culture nasal swabs not cost effective
Diagnosis is clinical in Acute Sinusitis
Indications for Imaging
Complicated sinusitis , Chronic or recurrent sinusitis , Sinusitis refractory to maximal medical
therapy
Imaging is not needed in routine cases Empiric therapy for 1-2 courses is appropriate
1. Sinus X-Ray (Sinus CT preferred) Plain radiographic signs consistent with sinusitis
include greater than 6 mm of mucosal thickening in adults and 4 mm in children,
greater than 33% loss of air space volume in the maxillary sinuses, or opacification–airfluid levels.
Single Waters' View X-Ray is sufficient
Indication (rarely indicated unless CT not available)
Sinus CT (gold standard) Indications
Complicated Acute Sinusitis & Suspected Chronic Sinusitis
Osteomeatal complex occlusion
Complicated acute sinusitis orbital cellulitis etc
Chronic Sinusitis
Recurrent Sinusitis
Allergic Fungal Sinusitis
Sinus MRI
No advantage over Sinus CT (and more false positives)
Indications : Suspected neoplasm and Fungal Sinusitis
16. Acute Sinusitis - Complications
Unless severe symptoms of acute sinusitis develop, such as fever,
facial pain or tenderness, or periorbital swelling, antibiotics
should be withheld for 10 to 14 days.
Complications : Orbital Cellulitis, Meningitis, Extradural
abscess , Subdural abscess , Brain abscess , Osteomyelitis and
Cavernous Sinus Thrombosis
Symptoms: Red Flag (consider immediate ENT referral)
High Fever over 102.2 F (39 C) or peristent fever
Visual complaints (e.g. Diplopia)
Periorbital edema or erythema ( check for EOMs ?pain)
Mental status changes
Severe facial or dental pain
Infraorbital hypesthesia
consider referral in immunodeficiency or if persistent symptoms
despite treatment
17. Sinusitis - Treatment
General Measures
Symptomatic relief : Warm, moist compresses over sinuses ,
Tylenol
Nasal Saline spray (2% buffered saline)
Systemic Decongestant: Pseudoephedrine
Mucolytic : Guaifenesin (e.g. Mucinex) 600 to 1200 mg PO bid
there is no evidence that mucolytics are useful adjuncts
Topical Decongestant (Maximum of 3 days of use)
Oxymetazoline or Phenylephrine (Neo-Synephrine)
Intranasal Steroid (treat for 3-6 weeks minimum)
Effective Decongestant
Also use as pretreatment prior to Intranasal Steroid
Effective in recurrent Sinusitis when used daily
Chronic Sinusitis
Nasal Polyp
Avoid Antihistamines!!
Dries secretions and Impedes osteomeatal complex drainage
18. Sinusitis - Treatment
ANTIBIOTICS:
Indicated only in acute bacterial Sinusitis
Protocol Antibiotic course Minimum course: 10-14 days
Longer course for persistent symptoms: 28 days
Change antibiotic if no improvement in 3 days REMEMBER
THAT Beta-lactamase resistance in acute cases: <30% , Betalactamase resistance in chronic cases: 40-50%
First-Line Indications to start on first-line agents Mild to
moderate symptoms , No daycare exposure & No recent
antibiotic use
Amoxiicillin Disadvantages: Misses Beta-lactamase
producers : Haemophilus Influenzae , Moraxella catarrhalis &
Penicillin Resistant Pneumococcus (increasing)
Trimethoprim Sulfamethoxazole (Bactrim) No longer
recommended as first-line agent , Higher resistance rate than
other agents
Disadvantages : Misses Staphylococcus , Risk of Toxic
Epidermal Necrolysis& Risk of Steven's Johnson
Syndrome
19. Sinusitis - Treatment
Second-Line Indications to start on
second-line agents : Severe symptoms Daycare
exposure , Recent antibiotic use
Amoxicillin-Clavulanate (Augmentin ) or
Cefuroxime (Zinacef) , Cefpodoxime
Avoid Cefixime ( poor Gram + coverage )
Third Line recommendation If no
improvement with above a) Consider adding
Flagyl to second-line agents b) Consider
second-line agent for longer course (4 week)
c) Switch to Fluoroquinolone (avoid under 16
yrs of age ), Moxifloxacin or Gatifloxacin
(Tequin)
20. Sinusitis - Treatment
Management : Penicillin or Cephalosporin Allergy
Macrolide antibiotics (High bacterial resistance rate)
Erythromycin , Azithromycin (Zithromax) or
Clarithromycin (Biaxin)
Trimethoprim-Sulfamethoxazole (Bactrim) Increasing
bacterial resistance, So other agents are preferred for
Sinusitis
Clindamycin Consider in combination with Rifampin
if severe , Poor efficacy against Gram Negative Bacteria
Fluoroquinolones ( avoid under age 16 years )
21.
Sinusitis - Treatment
“Unless severe symptoms of acute sinusitis develop, such as fever, facial pain or tenderness, or periorbital swelling, antibiotics should be
withheld for 10 to 14 days. Although the primary therapy for acute bacterial sinusitis is antibiotics, increasing resistance to penicillin may
days.
necessitate the use of alternative antibiotics. The choice of antibiotics is based on predicted efficacy, cost, and adverse effects. A 10- to 14day course is generally adequate for acute disease, but shorter courses may be indicated for newer antibiotics. If there is no improvement
in 3 to 5 days, an alternative antibiotic should be considered” ( guidelines, journal of clinical immunology, 2006)
considered”
Primary therapy for acute bacterial sinusitis is antibiotics with a 10to 14-day course considered adequate. Amoxicillin is a drug of
choice with trimethoprim-sulfamethoxazole an alternative.
If no response occurs within 3 to 5 days, a change to high-dose
amoxicillin-clavulanate, cephalosporins, or macrolides may be
indicated.
In areas of high antibiotic resistance or with failure to improve after
21 to 28 days, broad spectrum single agents should be considered,
such as amoxicillin-clavulanate, cefuroxime, or cefpodoxime, or use
of anaerobic coverage, such as clindamycin or metronidazole.
Nasal corticosteroids are indicated in acute and chronic sinusitis
and short-term adjunct oral steroids may be used after failure of
response or when nasal polyps are present.
Saline nasal sprays may help to reduce crusting!!
22. Acute Pharyngitis
Symptoms: Sore throat , Dysphagia & Odynophagia (pain with swallowing)
Generalized symptoms : Fever, Chills, Malaise, Headache , Abdominal Pain ,
Nausea or Vomiting
Symptoms suggestive of viral illness: Coryza, Conjunctivitis & Hoarseness
Signs
Viral
Non-exudative pharyngeal erythema
Exception: Tonsillar exudate in Mononucleosis (EBV)
Vesicular OR ulcerative oral lesions
Conjunctivits in Adenovirus and Kawasaki Disease
Group A Streptococcus and other bacteria clues are Enlarged tonsils with or
without exudate , Petechiae on Soft Palate (pathognomonic) , Erythema , Tender
cervical Lymphadenopathy
Strawberry Tongue (in Scarlet Fever)
Peritonsillar Cellulitis or Peritonsillar Abscess Suspect Unilateral erythema
of Soft Palate , Uvula deviated , Dysphagia, Odynophagia & Fever
Diphtheria Suspect when Gray membranous exudate covers tonsils and
pharynx or Exudate bleeds easily on removal
Kawasaki Disease Suspect when Pharyngitis with strawberry Tongue in age
<5 years , Non-purulent Conjunctivitis (also in Adenovirus) & Palmar erythema
and cracked red lips after 3 days
23. STREP THROAT
Acute Pharyngitis caused by Group A beta
hemolytic streptococci.
Most common in children 5-12 yr old
Infectivity Decreases 1-3 days after
antibiotic started
Return to School and day care
recommendations Child should receive
Antibiotics for minimum of 24 hours and
Afebrile
25. Strep Throat – Strep Score
Original Criteria (interpretation
below based on these) 1
point for each
Tonsillar exudate
Tender, anterior cervical
adenopathy
Cough absent
Fever present
Modifiers : Age younger
than 15 years: +1 point,
Age 15 to 45 years: 0 points
& Age over 45 years: -1
points
ER and OP probability:
Score 0: Streptococcus
probability 1% (3% in ER)
Score 1: Streptococcus
probability 4% (8% in ER)
Score 2: Streptococcus
probability 9% (18% in ER)
Score 3: Streptococcus
probability 21% (38% in
ER)
Score 4: Streptococcus
probability 43% (63% in
ER)
26. Strep throat (?) - Approach
Strep Score 4 (or Strep Score 2 if patient unreliable)
Treat with antibiotics
Strep Score 2 to 3: Perform rapid antigen test
Antigen test positive: Treat with antibiotics
Antigen test negative: Throat Culture (Requires 24 hour
minimum for adequate growth ) most specific (99%).
Sensitivity 90%. Not recommended as primary test due to
24 hour delay . Remember that –ve Rapid strep does not
rule out Strep throat
Strep Score 0 to 1
Provide Pharyngitis Symptomatic Treatment salt water
gargles, sucking candies, ibuprofen
27. Strep throat - Antibiotics
Penicillin is the first choice ( coz its strep)
penicillin VK 500 mg If using this standard course
duration is 10 days. Alternatively use Amoxicillin
500 bid in adults/ 10 days
Alternative antibiotics : Five days of alternative
antibiotics effective Amoxicillin Clavulanate
(Augmentin) , Ceftibuten, Cefuroxime,
Clarithromycin or Erythromycin estolate ( for pen
allergic pts)
Non-Compliant pts single dose benzathine
penicllin IM
Recurrent Strep Throat Cephalosporins are choice
( Keflex cephalexin 500 bid) or can use
Augmentin
28. Etiologies for recurrent Streptococcal Pharyngitis
Poor Compliance with oral medications (most common)
Day 3: 50% stopped antibiotics
Day 6: 70% stopped antibiotics
Day 9: 80% stopped antibiotics
Families reporting taking all the medication: 80%
Repeat exposure in crowded conditions
School , Daycare & Home or workplace
Eradicated protective throat flora by prior antibiotic
a-hemolytic Streptococcus is protective normal flora
Cephalosporins apparently do less harm
Selected beta-lactam resistance by prior antibiotic
Consider Augmentin for 10 day course
Suppressed Immune response from prior antibiotics
Antibiotic Resistance
Penicillin resistance is infrequent in strep throat
Macrolide (Erythromycin, Biaxin, Zithromax)
Resistance 2-8% in U.S.
Chronic Pharyngeal Carriage of Streptococcus pyogenes
Consider Pharyngitis due to another cause
30. Contraindications to school attendance
Infectious
Fever
Vomiting or dehydration
Indications for school return in viral infection
Viral infection examples : Influenza, Rhinovirus (Common Cold) , Fifth
Disease, Hand Foot and Mouth Disease
Indications to return to school No fever and Child must practice good
hygiene (i.e. hand washing)
Indications for school return in bacterial infection
Bacterial infection examples: Impetigo, Bacterial Conjunctivitis,
Streptococcal Pharyngitis (Strep Throat)
Indications to return to school after Antibiotics for 24 hours
Indications for school return in specific conditions
Chicken Pox All lesions have crusted over
Head Lice After anti-lice shampoo and manual nit removal
Pinworm Day after Pyrantel, Mebendazole, or Albendazole
Vomiting 24 hours after last Emesis
Conditions allowing immediate school return
Viral Conjunctivitis (Pink Eye)
Otitis Media (ear infection)
35. Whether to admit?
Most Pneumonias are treated as Outpatient
Admission is required if:
Those with underlying immunosuppression
( chemotherapy, HIV)
Elderly patients > 65 yrs
Pts with altered mental status
Those with hemodynamic ( shock) or respiratory
compromise ( tachypnea, respiratory failure)
Pts with poor social support ( homeless) or
without ability to self supervise
36. Where to Admit?
Admission to ICU is needed if:
LOOK AT VITALS!
Hypotension (SBP<90)
Hemodynamic Instability/ Shock (map<60)
Hypoxemia<60
Organ failure ( ARF etc)
Impending respiratory failure that may require
mechanical ventilation ( persistent tachypnea,
desaturation etc)
Deteriorating comorbid illness ( CHF, renal failure
etc)
Heart failure, severe copd exacerbation, Diabetic
complications (?DKA)
37. Community acqd
Outpatient Rx with Macrolide
( azithromycin) or newer Quinolones
Inpatient Rx with Ceftriaxone + macrolide
or Fluoroquniolone alone
38. Health Care Associated Pneumonia
Either NH associated or hospital acquired
NH associated pneumonia may have MRSA and
Gram –ve bacteria as etiologies ( E.coli, proteus,
klebsiella) so emperically Rx with Vanco +Zosyn
(pip/tazo) before sputum culture results are available.
Once Cx and sensitivity are obtained d/c the
antibiotic that’s not needed
Hospital acquired pneumonia is the one that develops
48 hrs after hospitalization has a different
spectrum of bacteria ( MRSA + resistant gram –ves)
initially can start VANCO + Zosyn before cx
results are available. If severe, use imipenem instead
of Zosyn (pip/tazo)
39. VAP
Ventilator Acquired Pneumonia Pneumonia that develops 48
hrs after intubation diagnosed by c/f like fever, leucocytosis,
newly developed CXR infiltrates and purulent ET tube
secretions the spectrum of bacteria here is more resistant i.e;
MRSA+ Resistant gram –ves including P.aeruginosa start
emperical VANCO+Imipenem ( do not take chance with
resistance here)
Culture ET secretions, Get a CXR
Bronchoscopy may be required in pts showing no response and
also to differentiate b/w colonization vs. Infection Recovery of
bacteria in high concentrations from bronchoalveolar lavage
(BAL) >10,000 col/ml helps in differentiation of non infectious
from infectious causes of pulmonary infiltrates ( i.e; if the
colonies are this high think of infection other wise think of non
infectious cause like ARDS, CHF etc for explaining these
pulmonary infiltrates in vent patients)
40. PCP
•
•
Pneumocystis Carinii pneumonia Seen in
immunocompromised pts Pts who are HIV,{CD4< 200}
Immunocompromised and pts on high dose steroids
( prednisone>20mg/d),
Symps: dry cough, fever, chills, sob, chestpain
Needs high suspicion for diagnosis LDH will help when in
doubt, Gallium scan will help too
CXR Interstitial infiltrates, LDH high, Ground glass
appearance on CT scan, Sputum for silver staining, if
sputum –ve, bronchoscopy needed for diagnosis where you do
Bronchoalveolar lavage – silver staining
Get an ABG
Rx Simple pcp oral bactrim
Severe pcp iv bactrim + steroids ( make sure u give enough
i.e; prednisone 40mg bid or solumedrol 30mg iv bid Po2 <
70mm hg/ increased A-a > 35are indication for steroid Rx)
Sulfa allergy aerosolized pentamidine
41. Case Study
A 36-year-old woman is admitted to the medical
intensive care unit because of respiratory depression
resulting from a barbiturate overdose. She is intubated
and mechanical ventilation is begun. Physical
examination, except for her comatose condition, is
unremarkable. Chest radiography and arterial blood
gases are within normal limits. Which of the following
will minimize her risk of developing a nosocomial
infection?
( A ) Ventilator tubing changes every 12 hours
( B ) Elevation of the head of the bed to 45 degrees
( C ) Ceftriaxone, intravenously
( D ) Oropharynx polymyxin B spray every 8 hours
( E ) Enteral feedings by nasogastric tube
42. Ans.B
Patients who are mechanically ventilated in the
supine position have an approximately six fold
increased risk of developing pneumonia compared
with patients maintained in a semirecumbent position.
Elevation of the patient's head to 45 degrees may
reduce aspiration and nosocomial pneumonia.
Nosocomial pneumonia is a major cause of morbidity
and mortality in mechanically ventilated patients.
43. Case Study
A 21-year-old woman with cystic fibrosis diagnosed at 6 months of age is
evaluated because of increased dyspnea, blood-streaked purulent sputum,
decreased energy, and a 1.8-kg (4-lb) weight loss of 4 weeks’ duration.
She was last treated with intravenous antibiotics 12 months ago. Her
sputum cultures repeatedly grow a mucoid strain of Pseudomonas
aeruginosa. Her forced expiratory volume in 1 second (FEV1) has
decreased by 400 mL in 6 months and is now 47% of predicted. Chest
radiography shows diffuse bronchiectatic changes but no consolidation.
She takes replacement pancreatic enzymes, albuterol nebulization three
times daily, inhaled recombinant human Dnase once daily,and uses a flutter
device to aid expectoration. Which of the following is the best
management option at this time?
( A ) Tobramycin, inhaled, twice daily
( B ) Increase Dnase, albuterol nebulizations, and chest physiotherapy
( C ) Piperacillin and tobramycin, intravenously
( D ) Ciprofloxacin, orally, and tobramycin, inhaled, twice daily
( E ) Bronchoscopy
44. Ans.C
Patients with cystic fibrosis and a bronchitic
exacerbation of chronic bronchiectasis with
Pseudomonas aeruginosa require intravenous
antibiotics with two antipseudomonal agents for 2 to3
weeks.
The use of aerosolized tobramycin is indicated for
patients with chronic Pseudomonas colonization and
is associated with long-term improvement in forced
expiratory volume in 1 sec (FEV1) of about 10%, as
well as decreased need for hospitalization and
intravenous antibiotics, but it is not sufficient for an
exacerbation.
45. Pulmonary Embolism
Causes
Clinical features chestpain, sob, cough, leg
swelling
EKG – Sinus tachy, S1Q3T3
ABGs – resp alkalosis
Diagnosis v/q, d-dimer, high resolution CT
(Spiral CT scan) ( Serum D-dimer < 500ng/ml
Treatment – if shock or if no shock , if
anticoagulation is contraindicated
46. PE on EKG
Pulmonary embolism (acute cor pulmonale) :
Look for new signs of new signs of tachycardia;
complete or incomplete RBBB; the S1Q3T3
pattern; and/or right axis shift. There may be
inferior or RV injury patterns. The most
common cause of an S1Q3T3 pattern is a
completed inferior MI. Get a Right sided
EKG.
47. PE on CXR
Initial CxR may be
NORMAL. ( PIOPED study
showed that only 12% of
CXRs in pts with
angiographically proven PE
were interpreted as normal)
May show – Collapse,
atelectasis, consolidation,
small pleural effusion,
elevated diaphragm.
Pleural based opacities with
convex medial margins are
also known as a Hampton's
Hump
48. Hampton's Hump
Pleural based opacities with convex medial
margins are also known as a Hampton's Hump.
This may be an indication of lung infarction.
However, that rate of resolution of these
densities is the best way to judge if lung tissue
has been infarcted. Areas of pulmonary
hemorrhage and edema resolve in a few days
to one week. The density caused by an area of
infarcted lung will decrease slowly over a few
weeks to months and may leave a linear scar
49. PE on CXR
Westermark sign –
Dilatation of pulmonary
vessels proximal to
embolism along with
collapse of distal
vessels, often with a
sharp cut off.
51. Case Study
A 56-year-old man is evaluated in the emergency department because of
progressive swelling of the right lower extremity during the previous 5
days and right-sided pleuritic chest pain and dyspnea beginning 1 to 2
hours ago.On physical examination, his temperature is 38.2 °C (100.8 °F),
pulse rate is 105/min, respiration rate is 28/min, and blood pressure is
160/80 mm Hg. Cardiac and pulmonary examinations are unremarkable.
Arterial blood gases with the patient breathing room air are PO2, 78 mm
Hg; PCO2, 30 mm Hg; and pH, 7.48.Electrocardiography shows sinus
tachycardia and nonspecific ST-T wave changes, and chest radiography is
normal.Ventilation-perfusion scanning shows two unmatched segmental
defects. The D-dimer value is three times the upper limit of normal.
Which of the following is the most appropriate course of action?
( A ) Heparin
( B ) Helical computed tomography with contrast
( C ) Noninvasive studies of the lower extremities
( D ) Pulmonary angiography
52. Key Point
In patients with a high pretest probability of pulmonary
embolism
and high-probability ventilation-perfusion scanning,
additional
diagnostic testing is not necessary before initiating therapy.
53. Pneumothorax
Causes – Trauma, bulla rupture, necrotizing
pneumonia
Clinical features chest pain, dyspnea, shock
Ventilator associated Pneumothorax ? sudden
hypotension while on vent look at peak and
plateau pressures
Treatment needle thoracentesis, needle
thoracostomy, tube thoracostomy
54. ARDS
Diffuse pulmonary capillary damage leading to increased
permeability of alveolar capillaries pulm edema
Criteria 1) There should be a cause 2) PO2/Fio2 ( in
liter) Ratio, Po2/Fio2 < 300 ALI, <200 ARDS 3)
B/L CXR infiltrates 4) Should not be due to CHF; Clues:
2D ECHO EF Good/ no diastolic dysfunction. If in doubt
whether CXR infiltrates are due to CHF or ARDS
measure PCWP ( Swan Ganz insertion )
Ventilation strategies Low Vt ( 6cc/kg) ( prevent
overdistension injury) and High PEEP strategy ( reduce
derecruitment injury)
Causes TTP, Sepsis, Shock, Aspiration pneumonia,
chemical pneumonitis, Drugs like Heroin, Pancreatitis,
Burns, Drowning
55. Case Study
A 58-year-old man is admitted to the intensive care unit with increasing dyspnea after
developing influenza symptoms 3 days previously. On physical examination, his
temperature is 39.1 °C (102.3 °F), pulse rate is 110/min, and bloodpressure is 135/83 mm
Hg. He weighs 73 kg (161 lb). He is using accessory muscles of respiration, and he has
finecrackles throughout all lung fields. Cardiac examination is unremarkable, and no
edema is noted. Chest radiographyshows diffuse infiltrates throughout both lungs with
patchy areas of consolidation. The patient has a history of moderate obstructive lung
disease secondary to smoking. Several months before hospitalization his forced expiratory
volume in 1sec (FEV1) was 53% of predicted, and he had normal oxygen saturation and no
hypercapnia.Shortly after hospitalization, he is intubated because of increasing hypoxemia
and hypercapnia. Subsequent arterial blood gases with the patient breathing 100% oxygen
and 10 cm H2O of positive end-expiratory pressure are PO2, 68mm Hg; PCO2, 65 mm Hg;
pH, 7.23; and bicarbonate, 26 meq/L. Tidal volume is 450 mL, respiration rate is
25/min,inspiratory flow rate is 100 L/min, and inspiratory/expiratory ratio is 1:5. Peak
airway and plateau ventilatory pressures are 48 cm H2O and 32 cm H2O.
Which of the following is the best option?
( A ) Increase the tidal volume
( B ) Increase the respiration rate
( C ) Increase the positive end-expiratory pressure
( D ) Decrease the positive end-expiratory pressure
( E ) Administer sodium bicarbonate, intravenously
56. Key Points
Ans. E
In patients with acute respiratory distress syndrome, mortality was significantly
improved by ventilating patients with tidalvolumes of 6 mL/kg of ideal body weight
and keeping plateau ventilatory pressure at =30 cm H2O.
If changes in respirator settings required to prevent hypercapnia have associated
untoward effects, it is reasonable to allow arterial PCO2 to rise and, if necessary,
prevent acidemia by administration of buffer as in this case!! ( don’t increase tidal
volume here low Vt is good for this remember Permissive Hypercapnia)
Increasing PEEP is not good here. Raising PEEP is undesirable because this will
narrow the pressure difference between the plateau ventilatory pressure and the
PEEP, decreasing the pressure available to deliver the tidal volume. This will reduce
the tidal volume and exacerbate hypercapnia. PEEP should remain unchanged
because the patient has acceptable oxygenation with the present setting. The level of
PEEP cannot be reduced since reduction likely will lead to unacceptable hypoxemia.
The patient is barely at an acceptable level without any reduction.
Increasing the respiration rate likely will increase auto-positive end-expiratory
pressure (PEEP) in this patient with chronic obstructive pulmonary disease ( they
have proloned expiration!) by “breath stacking,” that is, delivering the next breath
before the previous breath is completely expired.This will also raise the plateau
ventilatory pressure above a desirable range.
57.
Case Study
A 57-year-old man with severe chronic obstructive pulmonary
disease is hospitalized with respiratory distress of 12 hours’
duration. Arterial blood gases with the patient breathing 35%
oxygen through a face mask are PaO2, 50 mm Hg; PaCO2, 70
mm Hg; and pH, 7.24. When seen as an outpatient 1 month
previously, his arterial blood gases while breathing room air
were PaO2, 58 mm Hg; PaCO2, 50 mm Hg; and pH, 7.37.
Despite maximal therapy, mechanical ventilation is required.
During controlled breaths, his peak airway pressure is 25 cm
H2O, and plateau ventilatory pressure is 12 cm H2O. The
arterial blood gases are checked after 1 hour. Which of the
following is the most desirable set of arterial blood gas
values?
( A ) Pa O2, 50 mm Hg; PaCO2, 45 mm Hg; pH, 7.44; FIO2, 0.3
( B ) Pa O2, 65 mm Hg; PaCO2, 52 mm Hg; pH, 7.38; FIO2, 0.4
( C ) Pa O2, 65 mm Hg; PaCO2, 40 mm Hg; pH, 7.48; FIO2, 0.4
( D ) Pa O2, 90 mm Hg; PaCO2, 60 mm Hg; pH, 7.32; FIO2, 0.5
( E ) Pa O2, 133 mm Hg; PaCO2, 55 mm Hg; pH, 7.41; FIO2,
0.6
58. Ans.B
When instituting mechanical ventilation in a patient with
chronic hypercapnia, it is critical to avoid the development of
respiratory alkalemia secondary to overventilation, and
ventilator settings should have pH as a target, rather than
PaCO2.
When seen 1 month before hospitalization, the patient had
chronic carbon dioxide retention. When instituting mechanical
ventilation in a patient with hypercapnia, it is critical to avoid
the development of respiratory alkalemia secondary to
overventilation. Severe alkalosis in this setting may result in
cardiovascular instability, arrhythmias, andseizures. Ventilator
settings should have pH as a target, rather than PaCO2.
59. Acute Pulmonary Edema
Treatment morphine, loop diuretics in LVF,
Ventilation strategies in ARDS and
Hemodialysis when indicated
Causes ARDS, Acute LVF, Fluid Overload,
Missing Hemodialysis
60.
A 58-year-old man is admitted to the intensive care unit with increasing dyspnea after developing influenza
symptoms 3 days previously. On physical examination, his temperature is 39.1 °C (102.3 °F), pulse rate is
110/min, and blood pressure is 135/83 mm Hg. He weighs 73 kg (161 lb). He is using accessory muscles of
respiration, and he has fine crackles throughout all lung fields. Cardiac examination is unremarkable, and
no edema is noted. Chest radiography shows diffuse infiltrates throughout both lungs with patchy areas of
consolidation. The patient has a history of moderate obstructive lung disease secondary to smoking.
Several months before hospitalization his forced expiratory volume in 1 sec (FEV1) was 53% of predicted,
and he had normal oxygen saturation and no hypercapnia. Shortly after hospitalization, he is intubated
because of increasing hypoxemia and hypercapnia. Subsequent arterial blood gases with the patient
breathing 100% oxygen and 10 cm H2O of positive end-expiratory pressure are PO2, 68 mm Hg; PCO2,
65 mm Hg; pH, 7.23; and bicarbonate, 26 meq/L. Tidal volume is 450 mL, respiration rate is 25/min,
inspiratory flow rate is 100 L/min, and inspiratory/expiratory ratio is 1:5. Peak airway and plateau
ventilatory pressures are
48 cm H2O and 32 cm H2O.
Which of the following is the best option for improving this patient’s acid–base disorder?
( A ) Increase the tidal volume
( B ) Increase the respiration rate
( C ) Increase the positive end-expiratory pressure
( D ) Decrease the positive end-expiratory pressure
( E ) Administer sodium bicarbonate, intravenously
61. Ans.
In patients with acute respiratory distress syndrome,
mortality was significantly improved by ventilating
patients with tidalvolumes of 6 mL/kg of ideal body
weight and keeping plateau ventilatory pressure at
=30 cm H2O.
If changes in respirator settings required to prevent
hypercapnia have associated untoward effects, it is
reasonable to allowarterial PCO2 to rise and, if
necessary, prevent acidemia byadministration of
buffer.
63. COPD – Screening with Spirometry
Consider screening smokers or former smokers with
certain clinical characteristics for COPD with pulmonary
function testing.
In patients who smoke or have smoked, consider obtaining
screening spirometry readings to document obstruction if they
give a history of cough or sputum production or have findings
compatible with emphysema on chest x-ray.
Obtain spirometry readings if the patient has limiting
symptoms such as dyspnea inappropriate to the level of
activity, frequent episodes of acute bronchitis related to upper
respiratory tract infections (i.e., a possible acute exacerbation),
difficulty sleeping due to cough and dyspnea, and general
diminished activity levels and energy from difficulty in
breathing.
If the patient has no other clinical characteristics for COPD,
but has a significant history of smoking, consider obtaining
spirometry readings because significant pulmonary function
impairment may still be present.
64.
COPD Exacerbations
COPD – Chr.bronchitis, Emphysema – blue bloaters, Pink puffers
COPD exacerbations History, Clinical exam, get pulse ox,
Mild, Moderate, Severe classify depending on 3 criteria (Increase in
amount of sputum, Increased sputum purulence, worsening dyspnea)
Mild exacerbation ( 1 of above criteria) use simple antibiotics like
Bactrim or Doxycycline
Moderate exacerbation ( 2 of above criteria) use 2nd line Antibiotics like
quinolones, b-lactam/clavulanate ( Augmentin)
Severe Exacerbation ( 3 of above criteria) Look at the ABGs, o2
inhalation, nebulizer with ipratropium + albuterol caution with o2, o2
inhalation only as much as to maintain sao2>90%. If no response , non
invasive ventilation ( positive pressure ventilation, BIPAP) Pt must be
cooperative for this if altered mental status, no response with non invasive
ventilation Intubate and ventilate.
Remember to get ABGs after u place a COPD guy on oxygen
Beware of posthypercapnic alkalosis if develops, acetazolomide
COPD exacerbation ? Ask urself secondary to what Acute bronchitis,
pneumonia use of antibiotics in COPD exacerbations
Steroids is a MUST methylprednisolone high doses 125mg q6hrs, then
tapering steroids
65. When To Admit?
Indications for hospitalization of patients with COPD:
Patient has acute exacerbation plus one or more of the following:
Inadequate response of symptoms to outpatient management
Inability to walk between rooms (patient previously mobile)
Inability to eat or sleep due to dyspnea
Conclusion by family, physician, or both that patient cannot manage at home and
supplementary home care resources are not immediately available
Presence of a high-risk comorbid condition, pulmonary (e.g., pneumonia) or
nonpulmonary
Prolonged, progressive symptoms before emergency department visit
Altered mentation
Worsening hypoxemia
New or worsening hypercarbia
Patient has new or worsening cor pulmonale unresponsive to outpatient
management
A planned invasive surgical or diagnostic procedure requires analgesics or
sedatives that may worsen pulmonary function
Comorbid conditions (e.g., steroid myopathy or vertebral compression
fractures) have worsened pulmonary function
66. Where To Admit?
Admit patients with COPD to an intensive care
unit if they meet specific criteria.
Confusion, lethargy, or respiratory muscle fatigue
Persistent or worsening hypoxemia despite supplemental
O2 or severe or worsening of respiratory acidosis (pH
7.30); use of supplemental oxygen should be at the lowest
flow rate to raise PaO 2 >60 or SaO 2 >90% to avoid
hyperoxic hypercapnia
Need for assisted mechanical ventilation, whether through
means of tracheal intubation or noninvasive techniques
Severe dyspnea that responds inadequately to initial
emergency room therapy
67. COPD – Home Oxygen Therapy
At discharge, evaluate pt for home 02 therapy.
Especially at nights when pts may desaturate
( acidosis at nights shifts curve to right). Goal
maintain sao2 90 or po2 60
Indications :
Po2<55 or sao2 <85%
Po2 b/w 56 to 59 if corpulmonale or
polycythemia ( erythrocytosis) ( these
suggest evidence of hypoxia)
68. Lung Volume Reduction Surgery
Consider LVRS for patients whose initial clinical criteria
include:
CT scan evidence of bilateral emphysema
Prerehabilitation postbronchodilator TLC and residual volume >/= to
100% and 150% predicted, respectively
Maximum FEV1 </= 45% predicted
PaCO2 </= 60 mm Hg
PaO2 >/= 45 mm Hg
Completion of a pulmonary rehabilitation program
Do not consider LVRS for patients whose clinical criteria
include:
FEV1 less than or equal to 20% predicted ( very low for surgery) and
either homogenous emphysema or carbon monoxide diffusing capacity
less than or equal to 20% predicted (DLCO)
Non-upper-lobe emphysema and high baseline exercise capacity
69. Interpretation of PFT’S
Restrictive vs. Obstructive
FEV1 to FVC Ratio (Normally over 75%)
Not useful if both FEV1 and FVC are normal
Obstructive lung: Moderately to severely decreased
Restrictive lung: Normal or increased
Reversibility:
Bronchodilator response (Significant values)
Response suggests reversible component if
FVC or FEV1 improves by 12 to 15% over baseline
FVC or FEV1 increases by at least 200 ml
FEF25-75 improves by 15 to 25% over baseline
70. COPD Outpatient Rx
By MDIs Ipratropium all the time ( q6hrs)
+ albuterol as needed. Can use tiotropium
because its long acting
Evaluate for home o2 therapy
Steroids/ antibiotics in acute exacerbations
only. ( unlike in Asthma, steroids are not a
part of chronic therapy in COPD)
MDIs deliver only fixed dose of drug.
Nebulizers deliver larger dose of drug so in
exacerbation u start with nebulizer if MDIs
don’t work
71. COPD with Asthma
Asthma may be present in about 10% of cases
of COPD; however, reversibility of FEV1
alone should never be used to make a
diagnosis of asthma in the absence of other
supporting evidence such as a childhood
history of asthma, atopic symptoms, blood or
sputum eosinophilia, or onset of symptoms
before substantial history of cigarette smoking
73.
A 38-year-old man is evaluated because of a morning cough productive of clear sputum, chest
tightness, and shortness of breath when walking. He has smoked two packs of cigarettes per
day since his teenage years and says that previous chest radiography showed "early
emphysema." He is a baker but notes no improvement in symptoms when on vacation. His
wife has three indoor cats, and he has an outdoor dog. The patient has normal vital signs. The
chest is hyperresonant to percussion, breath sounds are decreased in intensity, and expiration
is prolonged. Pulmonary function tests show forced expiratory volume in 1 sec (FEV1) is 45%
of predicted, forced vital capacity (FVC) is 65% of predicted, total lung capacity (TLC) is
slightly increased (120% of predicted), and diffusing lung capacity for carbon monoxide
(DLCO) is moderately reduced (60% of predicted). Chest radiography shows hyperinflation
with a suggestion of several small bullae in the lower lung fields.
Which of the following tests is indicated?
( A ) Sputum Gram stain and culture
( B ) Methacholine inhalation challenge test
( C ) Skin tests for allergens and serum precipitins to wheat extract
( D ) Measurement of serum a 1-antitrypsin level
( E ) Esophageal pH monitoring for 24 hours
74.
Severe chronic obstructive pulmonary disease
in young persons is suggestive of a1antitrypsin deficiency, and an a1-antitrypsin
level should be measured.
Smoking is an important precipitating factor
and also increases progression
75. Case Study
A 67-year-old man with longstanding chronic obstructive pulmonary disease
(COPD) is hospitalized with a 1-week history of increasing cough productive
of large amounts of purulent sputum, low-grade fever, lethargy, and shortness
ofbreath.On physical examination, his vital signs are normal except for a
temperature of 38.2 °C (100.7 °F) and a pulse rate of 108/min. The neck veins
are not distended. The anterior–posterior chest dimension is increased and is
hyperresonant to percussion, breath sounds are reduced, and expiration is
prolonged.Arterial blood gases are normal except for a PO2 of 62 mm Hg with
the patient breathing 28% oxygen through a venturi mask. Chest radiography
shows changes compatible with COPD but no acute process.In the emergency
department, treatment with inhaled bronchodilators and antibiotics was begun.
Which of the following options is the best choice?
( A ) Add inhaled fluticasone, every 12 hours
( B ) Add methylprednisolone, 500 mg intravenously once
( C ) Add methylprednisolone, 125 mg intravenously every 6 hours for 3 days,
then taper over 2 weeks
(D) No need to add steroids in this patient
E) Intubate the patient
76. Key Point
Patients with exacerbations of chronic obstructive
pulmonary
disease (COPD) who receive intravenous corticosteroids
and a
tapering dose of prednisone over 2 weeks experience
shorter
hospitalization and less treatment failures.
Two weeks of tapering prednisone is just as effective as 8
weeks
in treating exacerbations of COPD.
77.
A 57-year-old man with severe chronic obstructive pulmonary disease is
hospitalized with respiratory distress of 12 hours’ duration. Arterial blood gases
with the patient breathing 35% oxygen through a face mask are PaO2, 50 mm Hg;
PaCO2, 70 mm Hg; and pH, 7.24. When seen as an outpatient 1 month previously,
his arterial blood gases while
breathing room air were PaO2, 58 mm Hg; PaCO2, 50 mm Hg; and pH, 7.37.
Despite maximal therapy, mechanical
ventilation is required. During controlled breaths, his peak airway pressure is 25 cm
H2O, and plateau ventilatory
pressure is 12 cm H2O. The arterial blood gases are checked after 1 hour.
Which of the following is the most desirable set of arterial blood gas values?
( A ) Pa O2, 50 mm Hg; PaCO2, 45 mm Hg; pH, 7.44; FIO2, 0.3
( B ) Pa O2, 65 mm Hg; PaCO2, 52 mm Hg; pH, 7.38; FIO2, 0.4
( C ) Pa O2, 65 mm Hg; PaCO2, 40 mm Hg; pH, 7.48; FIO2, 0.4
( D ) Pa O2, 90 mm Hg; PaCO2, 60 mm Hg; pH, 7.32; FIO2, 0.5
( E ) Pa O2, 133 mm Hg; PaCO2, 55 mm Hg; pH, 7.41; FIO2, 0.6
78. Q
65 Y/O comes with cough and exertional sob of several month duration. He has smoked for 35
years. On physical examination, he is sweating, ruddy, and cyanotic. His pulse rate is120/min
and regular, respiration rate is 30/min and labored, and blood pressure is 150/90 mm Hg. The
neck veins are distended to the angle of the jaw when sitting upright. The chest shows
hyperinflation, prolonged expiration, wheezing, and crackles at each posterior base. The
pulmonic sound is increased, and there is a summation gallop. An enlargedand tender liver
edge is felt 2 cm below the costal margin. He has marked dependent edema up to the
knees.The hematocrit is 55%, and leukocyte count is 8000/μL. Arterial blood gases with the
patient breathing room air arePaO2, 47 mm Hg; PaCO2, 50 mm Hg; and pH, 7.30. Spirometry
performed 2 years earlier showed a forced expiratoryvolume in 1 sec (FEV1) of 0.65 L and a
forced vital capacity (FVC) of 3.05 L. Chest radiography shows hyperinflation, clear lung
fields, and biventricular enlargement. Ventilation-perfusion lung scanning shows multiple
matched fillingdefects that are not segmental. Doppler studies of the legs are negative.After
treatment of the patient’s acute condition, which of the following is the best long-term
therapy for
this patient?
( A ) Nifedipine
( B ) Warfarin
( C ) Bosentan
( D ) Oxygen
( E ) Phlebotomy
79. Case Study
A 65-year old male hospital in-patient has smoked cigarettes since he was 18 years
old. He has a chronic cough and marked sputum production. When his doctor starts
to give him the usual talk about losing weight, he explains that since he has about
fifty pounds to lose, he has tried to exercise, but is unable to because of shortness
of breath with any activity. Upon further questioning, he comments that his
symptoms have been present for a very long time, but he was hospitalized due to a
marked exacerbation of his complaints. On auscultation, rhonchi and wheezes are
heard.His laboratory results are as follows:
pCO2 60 mm Hg(35-45 mm Hg)
pH 7.34( 7.35-7.45)
bicarbonate 31 mEq/L( 24 mEq/L)
Na+ 140 mEq/L( 135-145 mEq/L)
K+ 4.0 mEq/L( 3.5-5.5 mEq/L)
Cl-100 mEq/L(98-109 mEq/L)
What is the primary disorder?
a) metabolic acidosis with a normal anion gap
b) metabolic acidosis with an elevated anion gap
c) metabolic alkalosis
d) respiratory acidosis
e) respiratory alkalosis
80. Ans.D
This patient has symptoms and signs of chronic obstructive pulmonary
disease, specifically chronic bronchitis.
Symptoms and signs include cough, sputum production and dyspnea with
exertions. Patients tend to be stocky or overweight, as the case here.
Auscultation will reveal wheezes and rhonchi. This patient is retaining
CO2, since his pCO2 is elevated. CO2 is in equilibrium with carbonic acid.
An increase in CO2 will shift the Henderson Hasselbalch equation to the
left, resulting in acidosis. Since the cause of the primary problem is
respiratory, e.g. retention of CO2, this is a
respiratory acidosis.
This is reflected in the pH being reduced as well.Metabolic acidosis
(choice a, choice b) is incorrect because the primary problem is not due to
a administration of acid, excess metabolic acid formation, or loss of base.
Although the bicarbonate level is abnormal in this patient, that is due to
metabolic compensation for the respiratory acidosis.
Alkalosis (choice c, choice e) are incorrect because his pH is acidotic.
Although compensatory mechanisms can bring the pH towards the normal
range, compensatory mechanisms will never overshoot.
81.
A 54-year-old man is hospitalized because of severe shortness of breath, ankle
swelling, and confusion of 5 days’ duration. He has smoked for 35 years. On
physical examination, he is sweating, ruddy, and cyanotic. His pulse rate is
120/min and regular, respiration rate is 30/min and labored, and blood pressure is
150/90 mm Hg. The neck veins are distended to the angle of the jaw when sitting
upright. The chest shows hyperinflation, prolonged expiration, wheezing, and
crackles at each posterior base. The pulmonic sound is increased, and there is a
summation gallop. An enlarged and tender liver edge is felt 2 cm below the costal
margin. He has marked dependent edema up to the knees. The hematocrit is 55%,
and leukocyte count is 8000/μL. Arterial blood gases with the patient breathing
room air are PaO2, 47 mm Hg; PaCO2, 50 mm Hg; and pH, 7.30. Spirometry
performed 2 years earlier showed a forced expiratory volume in 1 sec (FEV1) of
0.65 L and a forced vital capacity (FVC) of 3.05 L. Chest radiography shows
hyperinflation, clear lung fields, and biventricular enlargement. Ventilationperfusion lung scanning shows multiple matched filling defects that are not
segmental. Doppler studies of the legs are negative. After treatment of the
patient’s acute condition, which of the following is the best long-term therapy
for this patient?
( A ) Nifedipine
( B ) Warfarin
( C ) Bosentan
( D ) Oxygen
( E ) Phlebotomy
82. Ans. D
In patients with cor pulmonale caused by
chronic hypoxemia, oxygen therapy is the
treatment of choice; it may decrease the heart
failure and polycythemia seen in this
condition.
83. Asthma
Classification: Management Grouping
Mild Intermittent Asthma
Mild Persistent Asthma
Daily symptoms with daily Beta Agonist use
Severe Persistent Asthma
Frequent exacerbations (>twice weekly, but not daily)
Moderate Persistent Asthma
Occasional exacerbations (Less than twice per week)
Continuous Symptoms and frequent exacerbations
Treatment short acting MDIs as needed, long acting bronchodilators
( once asthma becomes moderate to severe add these as adjuncts to inhaled
steroids), inhaled steroids ( first line agent in all persistent asthmas) ,
systemic steroids, monteleukast ( add this as adjunct in moderate to severe
asthma)
Status asthmaticus
84. Asthma
Examples of different therapeutic approaches:
Mild Intermittent: use only prn albuterol; if related to exercise,
use albuterol one-half hour prior to exercise; also used:
cromolyn one half-hour prior to exercise.
Mild Persistent: daily: low dose inhaled steroids; and use
albuterol intermittently as needed. May use inhaled cromolyn.
Moderate Persistent: use peak flow meter daily; use med dose
inhaled steroid or low dose steroids plus serevent or singulair.
Others switch to Advair. PO steroids prn.
Severe Persistent: use peak flow meter daily; po steroids as
needed. Daily meds to include high dose inhaled steroids,
singulair, serevent or possibly Advair.
85. Classification:
Mild
Mild
Mod
Intermitt Persist Persist Severe Persistent
ent
ent
ent
Sym
< 2 /
ptom
week
s
> 2 /
week
Daily
Continual
Night < 2 /
sx
month
> 2 /
month
> 1 /
week
Frequent
FEV
1
> 80% >
predicte 80%pre 60-80% < 60%
d
dicted
Peak
flow
< 20%
Varia
bility
20-30% > 30 % > 30%
87. Case Study
A 68-year-old man with asthma is evaluated because he needs
to use his albuterol inhaler at night once or twice a week after
waking up with chest tightness. His forced expiratory volume
(FEV) is 2.18 L (65% of predicted) before and 2.62 L(82% of
predicted) after inhaled albuterol. Current medications include
inhaled fluticasone, 440 μg twice daily, and an albuterol
metered-dose inhaler as needed. Which of the following
should be done next to better control his symptoms?
( A ) Increase fluticasone to 880 μg twice daily
( B ) Add salmeterol
( C ) Add prednisone
( D ) Add allergen immunotherapy
( E ) Add a long-acting theophylline at bedtime
88. Key Point
In patients with moderate-to-severe asthma not responding
to
adequate doses of a short-acting ß-agonist and inhaled
corticosteroids, the next step is addition of a long-acting
ß-agonist.
89. Case Study
A 25-year-old woman is evaluated because of a 3-year history of a
nonproductive cough. The cough is aggravated by bicycle riding and
occasionally awakens her from sleep. During the past year, she
experienced two episodes of bronchitis followed by a dry cough persisting
for 2 months. The cough worsened when she visited her sister in Alaska.
She has seasonal symptoms of watery, runny nose and sneezing. There is
no postnasal discharge, nasal congestion, heartburn, weight loss, or night
sweats. She does not smoke. Her physical examination and chest
radiography are normal. Spirometry shows forced expiratory volume in 1
sec (FEV1) 3.29 L; forced vital capacity (FVC), 4.13 L; and FEV1/FVC
ratio of 79%. Which of the following is the best next management step?
( A ) Chest computed tomography
( B ) Bronchoscopy
( C ) Methacholine inhalation challenge testing
( D ) Observation and reassurance
( E ) Therapeutic trial of a proton pump inhibitor
90. Cough Variant Asthma
Cough-variant asthma is nonproductive, provoked by
exercise
and cold air, disturbs sleep, and worsens after a lower
respiratory tract infection.
The inhalation of methacholine produces airway obstruction
in
most patients with asthma; less than 10% of normal persons
have positive responses ( false +ves) .
91. Case Study
A 45-year-old woman is evaluated because of dyspnea during exercise that
began when she started an aerobics class. She has dyspnea, chest tightness,
and a nonproductive cough after 15 minutes of vigorous step exercises.
The symptoms worsen slightly when she stops, then gradually abate. She
has a 5-pack-year smoking history but quit 10 years ago. The physical
examination, chest radiography, and electrocardiography are all normal.
Spirometry shows forced expiratory volume in 1 sec (FEV1), 2.72 L (83%
of predicted); forced vital capacity (FVC), 3.2 L(86% of predicted); and
FEV1/FVC ratio of 85%. Postexercise spirometry shows FEV1, 2.04 L
(25% drop from baseline),and FVC, 3.00 L (2% drop from baseline).
Which of the following management options should be done next?
( A ) Reassure the patient
( B ) Prescribe an albuterol inhaler 15 minutes before exercise
( C ) Perform an exercise stress test
( D ) Measure lung volumes and diffusing capacity
( E ) Perform high-resolution computed tomography of the chest
92. Ans.b
For patients with exercise-induced asthma, an
inhaled ß-agonist should be prescribed before
exercise.
93. Case Study
WHEN CONSIDERING THE DRUG TREATMENT
OF ASTHMA WITH INHALER DEVICES
A. The incidence of oral candidiasis is increased by
the use of spacer devices.
B. Salmeterol is indicated for p.r.n. usage.
C. Intermittent terbutalin has been shown to lead to
long term worsening of asthma.
D. Steroid dosage of 600mg daily has been shown to
be associated with adrenal suppression in adults.
E. Sodium cromoglycate is of no proven value in
treating acute asthmatic attacks
94. Ans.E
Spacer devices decrease the incidence of oral
candidiasis by preventing the deposition in the
mouth. Salmeterol is a long acting beta antagonist, its
action is slow in onset and therefore it should be
given regularly rather than p.r.n. The Committee on
Safety of Medicines has reported that salbutamol and
terbutaline have not been shown to lead to a
worsening of mild asthma. In adults an inhaled
dosage of steroid of 1,500 micrograms daily is
associated with adrenal suppression . Sodium
cromoglycate is of no value in and acute attack and is
only indicated for prophylaxsis.
95. OSA
Check for symptoms of excessive daytime sleepiness
Diagnose by sleep study.
Obesity – neck circumference > 17cm important
predictor.
Check local anatomy, Throat crowding, secondary
factors (thyroid, cushings) causing obesity.
Obesity Hypoventilation syndrome
Rx – c-pap at nights
96. Q
A 43-year-old man is evaluated because of uncontrolled hypertension,
documented in and outside of the office, despite moderate doses of
hydrochlorothiazide and enalapril. For the past 6 months he has noted
increased fatigue and irritability that he attributes to personal problems at
work. He admits to difficulty concentrating at work. He has two beers
before bed to fall asleep. He is a salesman, smokes one pack of cigarettes
per day, and lives alone. His neck circumference is 17.5 in. On physical
examination, he has a ruddy complexion, body mass index is 32, and blood
pressure is 158/88 mm Hg. Jugular venous distention cannot be evaluated
because of obesity. An S4 is present. The remainder of the examination is
normal. A complete blood count, serum electrolytes, serum creatinine,
blood urea nitrogen, electrocardiography, and chest radiography are
normal.
Which of the following is most likely to establish a diagnosis?
( A ) Ambulatory blood pressure monitoring
( B ) Pulmonary function studies
( C ) Polysomnography
( D ) Arterial blood gases and blood volume determination
97. Q2
A 58-year-old man is evaluated because of daytime sleepiness. He is
requesting an evaluation at this time because last week he fell asleep while
driving and had a minor accident. He is a lifetime nonsmoker and is
otherwise healthy. On physical examination, his body mass index is 26.
There are no obvious abnormalities of his oropharynx. Chest and cardiac
examinations are normal. There is no peripheral edema. Chest radiography
and electrocardiography are normal. Overnight polysomnography for 6
hours of sleep shows 60 episodes of apnea (cessation of airflow for more
than 10 seconds) per hour accompanied by frequent oxygen desaturation
below 85%. There is evidence of rib cage and abdominal motion during the
apneic periods. Which of the following is the most appropriate form of
therapy for this patient?
( A ) Nasal continuous positive-airway pressure
( B ) Uvulopalatopharyngoplasty
( C ) Progesterone
( D ) Mandibular repositioning device
( E ) Nocturnal supplemental oxygen by nasal cannula
98. Ans. A
Nasal continuous positive-airway pressure (CPAP) is the
standard initial treatment for patients with symptomatic
moderate-to-severe obstructive sleep apnea syndrome. It
works by splinting the upper airway in an open position.
Surgical procedures such as uvulopalatopharyngoplasty
(UPPP) and tracheostomy are best considered in severely ill
patients for whom more conservative measures such as nasal
CPAP are ineffective.
Although tracheostomy cures obstructive sleep apnea, it
carries associated complications and is poorly accepted by
patients. UPPP, whether performed with conventional or laser
surgery, has variable long-term results and also has associated
complications.
100. Sarcoidosis
Diagnosis
Pulmonary Function Testing
Serum Angiotensin-converting enzyme (Serum ACE)
Findings consistent with Interstitial Lung Disease
Increased in 50-80% of Sarcoidosis patients
Biopsy or Cytology (Gold standard)
Finding
Discrete noncaseating epithelioid granuloma
Biopsy sites
Transbronchial lung biopsy (preferred site)
Bronchoalveolar lavage (CD4-CD8 ratio >3.5)
Skin biopsy of lesion
Palpable peripheral lymph node biopsy
Salivary Gland biopsy
101. Sarcoid - lung
Radiology: Chest XRay (abnormal in 90% of cases)
Type 0: No abnormality (<10% of cases)
Type I: Lymphadenopathy alone (43% of cases)
Type II: Adenopathy and Infiltrates (24% of cases)
Bilateral hilar Lymphadenopathy
Mediastinal Lymphadenopathy
Right paratracheal Lymphadenopathy
Lymphadenopathy as in Type I Chest XRay findings
Parenchymal infiltrates
Symptomatic respiratory disease presentation
Type III: Infiltrates alone (13% of cases)
Parenchymal infiltrates
102. Sarcoidosis - Treatment
Cutaneous for Erythema nodosum use
NSAIDS, For sarcoid lesions use intralesional
Corticosteroids
For uveitis topical CS, Systemic CS if
refractory
For pulmonary sarcoidosis stage 2 or 3
Indications : Dyspnea , Persistent cough and
Widespread debilitating disease systemic CS/
AZA
103. Sarcoidosis - Prognosis
Prognosis
Overall mortality (from respiratory failure): 1-5%
Factors suggestive of worse prognosis
Onset after age 40 years
Black race
Chronic Hypercalcemia
Specific higher risk organ involvement
Neurologic involvement
Cardiac involvement
Eye involvement (Chronic Uveitis)
Renal involvement (Nephrocalcinosis)
Cystic bone lesions
Progressive pulmonary fibrosis
105. TB - Screening
Screen for LTBI in persons at increased risk of recent infection, including
immigrants within the last 5 years from high prevalence countries; pre- and
postexposure in travelers visiting countries with a high prevalence of TB;
those in recent contact with a case of infectious TB; health care workers
with potential exposure to mycobacteria; and residents and employees of
high-risk congregate settings where local epidemiology indicates a high
rate of TB.
Screen for LTBI in persons with conditions associated with an increased
risk of developing active TB, including HIV infection, diabetes, silicosis or
exposure to silica dust, low body weight, chronic renal failure or
hemodialysis, gastrectomy, jejunoileal bypass, cirrhosis of the liver, organ
transplantation, anticancer chemotherapy and other immunosuppression
(e.g., TNF-α antagonists), malignant head or neck carcinoma, or fibrotic
changes on CXR film compatible with previous TB.
Screen children and adolescents for LTBI who have risk factors for
development of active disease (e.g., HIV), have been exposed to adults at
high risk for TB, or have been adopted from abroad, especially if they were
born in countries with endemic TB.
106. TB - Screening
PPD test is used for screening and its sensitivity
approaches 100% in pts with normal immunity.
As an alternative to the PPD, consider using a wholeblood IFN-γ assay such as QuantiFERON-TB Gold,
recognizing its limitations in children and
immunocompromised patients and that all currently
available studies on the sensitivity and specificity of
this test are limited by the lack of an eternal “gold
standard” for the diagnosis of tuberculous infection,
but that there is good reason to believe that the
QuantiFERON-TB Gold test is superior to the TST in
BCG-vaccinated individuals because it employs the
ESAT-6 antigen that is lacking in BCG
107. TB and PPD
Interpretation: PPD under 5 mm
Negative
Observe Patient
Interpretation: PPD 5 mm or greater
Positive if
HIV Infection
Tuberculosis contact
Immunosuppressed (e.g. HIV, Prednisone >15 mg qd)
Abnormal finding on Chest XRay
Management
Chest XRay and exam for disseminated disease
If cxr –ve INH for 9 mos
108. TB and PPD
Interpretation: PPD 10 mm or greater
Positive if
Health care workers
New immigrant within last 5 years
Intravenous Drug Abuse
Homeless
Under 4 years old
Malnutrition
Diabetes Mellitus
Silicosis
Tuberculosis endemic to region
Management
Chest XRay and exam for disseminated disease
109. TB and PPD
Interpretation: PPD 15 mm or greater
Positive in all persons
Management
Chest XRay and exam for disseminated disease
INH 9 mos if no active disease ( i.e; you are treating
Latent TB)
If active disease First step Sputum for AFB smear x
3, Sputum for AFB cx and Sensitivity; isolate the
patient, isolate organism for susceptibility testing
start emperic multi drug regimens HRZE
For failure/ resistant TB SHRZE
Sputum –ve pts can be taken off Isolation.
110. Latent TB – Imp Points
In case of patients who are TB contacts:
Do PPD test and if –ve repeat another after 8-12 wks
Begin latent TB therapy in contacts such as children
and patients with HIV even if the initial skin test is
negative.
If the second test is also negative, stop medication in
immunocompetent individuals. If a known high-risk
TB exposure has occurred in a patient with HIV
infection, continue LTBI treatment for the full period,
regardless of TST results.
111. Tuberculosis & PPD – Imp Points
PPD skin test
Next step if ppd +ve ( Latent TB)
INH rx
When screening for LTBI in TB contacts, if the initial
PPD result is negative a second PPD should be done
8 to 12 weeks after the last known exposure ( In a
review of literature, several studies support a
maximum interval of 8 weeks from initial infection to
development of a delayed-type hypersensitivity
reaction. A Tuberculin Skin Test > 8 weeks from last
exposure is recommended. )
112. Tuberculosis & PPD – Imp Points
Do not do a Tuberculin Skin Test on any patient
with a history of severe blistering reactions
with previously documented active TB, With a
history of treatment for TB, With a documented
previous positive TST result because the TST
remains positive in most of these patients
Do not use TST to see if it turns –ve to monitor
the success of your treatment that wont
happen TST remains +ve even after therapy.
113. Tuberculosis & PPD – Imp Points
Delay the PPD Test for 4 to 6 weeks after a
major viral illness such as measles, mumps,
rubella, or influenza, because cutaneous anergy
can develop, leading to a false-negative TST
result.
Do periodic serial PPD screening in persons
with ongoing exposure to TB ( Health Care
Workers, Residents) q1year is good enough!
115. Common Causes of Chronic Cough
Smoker’s cough
Chronic bronchitis due to smoking
Post-nasal drip
Post-infectious Viral Bacterial—Bordetella
pertussis, Mycoplasma, Chlamydia
( tracheobronchitis)
Gastroesophageal reflux disease
Asthma
Angiotensin converting enzyme inhibitors
116. Less Common Causes of Chronic
Cough
Infectious causes
Tuberculosis—typical or atypical,
Fungal
Endobronchial lesions
Benign — bronchial adenoma, carcinoid tumor
Malignant — bronchogenic carcinoma, metastatic cancer
Foreign body
Interstitial lung diseases
Hypersensitivity pneumonitis
Bronchiolitis obliterans with organizing pneumonia, ( BOOP)
Sarcoidosis
Chronic interstitial pneumonia
Chronic aspiration
Masses in the neck/thyroid disorders
Hair impinging on the tympanic membrane
Bronchiectasis
Occult congestive heart failure
Disorders of the pleura, pericardium, diaphragm
Psychogenic/habitual cough
Occupational bronchitis
Enlarged tonsils or uvula
117. History
The cause(s) of chronic cough may become apparent after
taking a careful history.
Is the symptom a cough or “hawking” or clearing the throat?
It helps to have the patient act out the cough to distinguish
true cough from throat clearing.
Is the cough dry or productive? If so, what is produced?
Are systemic symptoms such as fever, night sweats or weight
loss present?
A detailed history of the work and home environment should
be taken with emphasis on possible exposure to noxious
inhalants or allergens. The history should include the time and
circumstances of onset, frequency, and aggravating and
relieving factors.
Patients with asthma may note worsening of cough on
exposure to cold air, irritants or allergens. Is there an allergic
history? Does the patient wheeze with cough?
118. HISTORY
Is the cough accompanied by dyspnea? If so, congestive heart
failure or interstitial lung disease may be suspected.
Is the cough related to time of day, eating or position? A
nocturnal cough may be associated with asthma, post-nasal
drip, congestive heart failure or gastroesophageal reflux
disease (GERD). Half of the patients with GERD have none of
the classic symptoms.
Does the patient cough while eating? Chronic aspiration is
common in the elderly patient, especially following stroke.
Is the patient on angiotensin converting enzyme inhibitors or
other drugs that may predispose to cough or asthma?
Do not overlook ophthalmic preparations. Beta blocker eye
drops may precipitate asthma.
119. Physical
The physical examination may provide clues to the
causes of cough.
Examination of the upper airways may show nasal
mucous membrane swelling, post-nasal drip or nasal
polyps.
The finding of wheezes, rhonchi or crackles may
indicate asthma, bronchitis, COPD, interstitial lung
disease or congestive heart failure.
The finding of unilateral wheezing may be due to an
endobronchial lesion or foreign body.
Masses in the neck, including thyroid enlargement,
can compress the trachea and cause cough.
120. Diagnostic Tests
The work-up for chronic cough should begin with standard posterior- anterior and
lateral chest x-rays these often reveal the presence of underlying infectious or
neoplastic causes of chronic cough.
Spirometric studies before and after bronchodilator administration may reveal
reversible airways obstruction (asthma).
In patients with normal base-line spirometry methacholine inhalation challenge
(MIC) is indicated to rule out asthma that presents primarily with cough. ( COUGH
VARIANT ASTHMA)
Computerized tomograms (CT) of the sinuses are superior to plain x-rays in
identifying sinusitis.
High-resolution or spiral CT scans of the thorax may reveal subtle changes
consistent with cough due to chronic interstitial pneumonia or bronchiectasis.
The finding of a reduced single breath diffusing capacity (DLCO) may suggest
interstitial lung disease.
Barium esophagograms and upper gastrointestinal endoscopy have a low sensitivity
(48%) and specificity (76% ) for identifying GERD as the culprit in chronic cough
monitoring the esophageal pH for 24 hours is the gold standard. ( If cough is the
only symptom of GERD it gets difficult to diagnose so, 24hr Ph monitoring)
In patients suspected of having chronic aspiration, a video swallowing study with a
speech therapist in attendance should be performed. ( SWALLOW
EVALUATION)
A systematic approach to the work-up of a patient with nondrug-related chronic
cough is presented in THE NEXT SLIDE. If you suspect Drug related cough
stop the drug and observe
121.
122. Chronic Cough
Post-nasal Drip Syndrome
Post-nasal drip syndrome is said to be one of the most
common causes of chronic cough and is caused by a variety of
conditions including vasomotor rhinitis, allergic rhinitis, nasal
polyps and chronic sinusitis.
The diagnosis is made on clinical grounds.
Patients may complain of a tickle or drainage of liquid in the
back of the throat.
On examination, cobblestoning of the nasal or oropharygeal
mucosa may be observed. In many patients cough may be the
only symptom of post-nasal drip syndrome.
Confirmation of the diagnosis may depend on the resolution of
symptoms after treatment with antihistamines and intranasal or
systemic corticosteroids.
123. Chronic Cough
Asthma & Cough-variant Asthma
Typically, asthma patients complain of episodic wheezing, cough,
chest tightness and dyspnea and demonstrate reversible obstructive
air flow.
In so called cough-variant asthma a dry cough, particularly at
night, is the only symptom and routine spirometry is normal.
Diagnosis : Spirometry is normal in cough variant type The
diagnosis is often made on the basis of a favorable clinical
response to empirically administered beta2-agonist bronchodilators
and inhaled corticosteroids, and a positive bronchoprovocation test
using methacholine inhalation challenge (MIC) A positive MIC
test, defined as a 20% or greater decrease in the FEV1 after MIC,
indicates bronchial hyperreactivity but not necessarily asthma. For
example, bronchial hyperreactivity may follow viral respiratory
tract infections and persist for as long as 6 weeks. Because MIC
has a positive predictive value of from only 60% to 80%, Irwin and
colleagues advise that a positive test must be correlated with
favorable response to therapy before concluding that a patient has
cough-variant asthma.
124. Chronic Cough
Gastroesophageal Reflux-related Chronic Cough
GERD is a very common problem. Surveys of the general population have
led to estimates that 10% of the adult population of the United States have
daily heartburn and a third have intermittent symptoms; moreover, GERD
has been shown to cause 10% to 40% of cases of chronic cough Cough
in GERD is triggered by reflux of acid into the distal esophagus and
stimulation of an esophageal-tracheobronchial reflex. Cough is not
dependent on aspiration into the larynx or tracheobronchial tree.
Proving the relationship of chronic cough to GERD can be difficult. The
lack of typical symptoms of reflux and negative endoscopic and
radiographic studies do not rule it out.
The 24-hour esophageal pH monitoring test has become the gold standard
for diagnosis and has both a sensitivity and specificity approaching 90%.
Correlation of the results of pH monitoring with response to therapy adds
to the reliability of the test.
If GERD is the sole cause of chronic cough, aggressive anti-reflux therapy
should eliminate the cough in nearly all cases. One study reported 100%
success. Treatment involves the use of dietary, mechanical and drug
therapy. Drug therapy should be initiated with proton pump inhibitors for
GERD.
125. Chronic Cough
Post-infectious Cough
Patients who have had recent viral respiratory tract
infections may have prolonged cough that is
refractory to treatment. Airway hyperresponsiveness
can be demonstrated by MIC testing in some cases.
Treatment with bronchodilators and inhaled or
systemic corticosteroids in moderate to high doses
may help relieve symptoms. The cough can be selfperpetuating and cause continuing trauma to the
airways, and in these cases, prolonged suppression
with narcotics may eventually allow resolution.
Bordetella pertussis (the cause of whooping cough)
infection in adults should be included in the
differential diagnosis of chronic cough. In one series
of 75 patients with chronic cough lasting longer than
2 weeks, 21% had pertussis.
126. Chronic Cough
Angiotensin Converting Enzyme Inhibitor Cough
Angiotensin converting enzyme inhibitor (ACEI) drugs are frequently used
in the treatment of hypertension, congestive heart failure and myocardial
infarction. Ten to 20% of patents taking ACEI drugs develop cough. There
is no evidence at this time that any one ACEI drug is less likely to cause
cough than another. In spite of this well-documented side effect, referrals
to a specialist for evaluation of chronic cough still occur frequently. Many
of these patients have had extensive and costly work-ups and treatment
with a variety of medications, including antihistamines, antibiotics, cough
suppressants and corticosteroids, without relief.
Clinically, the cough may begin from as early as 3 weeks to as long as a
year after starting treatment. The severity of the cough can vary from a
mild tickle in the throat to a severe hacking, debilitating cough that
interferes with sleep, work and social function. It is frequently worse at
night and in the supine position.
When the ACEI drug is discontinued, the cough usually abates in 2 weeks
but may persist for months.
Angiotensin ll receptor antagonists have not been associated with an
increased incidence of cough.
127. Chronic Cough
Less Common Causes of Cough
Chronic cough may be the presenting
complaint in patients who ultimately prove to
have tumors, both benign and malignant,
sarcoidosis or other infiltrating lung diseases;
all these conditions require special
investigations to make the diagnosis.
Psychogenic or habitual cough does exist but
patients should not be put in this category
without an exhaustive work-up, failure of
empirical therapy and prolonged follow up.
128. Chronic Cough
Symptomatic Treatment
The treatment of cough is effective only if directed at the cause, but patients should
be offered symptomatic relief while awaiting the results of specific therapy.
Expectorants such as iodides and guaifenesin, hydration, inhaled steam, cough
lozenges and hard candies are helpful. Dextromethorphan and codeine are effective
cough suppressants.
When to Refer
When the patient with chronic cough remains symptomatic despite evaluation and
treatment for 6 to 8 weeks, the primary care physician should consider referral to a
specialist. In difficult cases referral to a pulmonologist for evaluation, therapy and
for specific testing such as fiberoptic bronchoscopy and MIC is recommended.
Referral for upper gastrointestinal endoscopy and 24-hour pH monitoring may be
indicated to rule out cough due to GERD. Referral to an allergist may be indicated
for allergy testing and subsequently for immunotherapy if the patient is sensitive to
an unavoidable antigen.
Medicolegal Issues
One of the most common reasons patients file suit is for failure to diagnose cancer.
Even though bronchogenic carcinoma is an uncommon cause of chronic cough
in the context of a normal chest x-ray, it must not be overlooked .
Failure to diagnose tuberculosis is another cause of litigation but again would be an
unlikely cause of chronic cough with normal chest roentgenograms .
130. Characteristics of Solitary
Pulmonary Nodules
Variable
Benign
Malignant
Age
< 30 years
> 50 years
Calcificati Popcorn, dense, None or minimal
on
concentric
Nodule
edge
Smooth, round
Irregular, spiculated
Smoking
history
Never smoked
> 20 pack-years
Size of
diameter
< 1.5 cm
> 1.5 cm
131. X-ray Characteristics of SPN
Benign nodule charecterestics : the presence of calcification, which can be
a diffuse speckled, or “popcorn,” pattern, typical of a hamartoma, or a
large central nidus or concentric calcification typical of a granuloma.
The second important factor distinguishing a malignant from a benign
nodule is the growth rate. Since the “doubling time” of a lung cancer
ranges from 15 to 450 days, the nodule that does not increase in diameter
over a two year period can be considered benign. Any lesion that increases
in size over a two year period of observation, or less, must be considered
malignant until proven otherwise. One exception is a nodule doubling in
less than 20 days, which usually suggests an acute inflammatory process.
The third important characteristic is the appearance of the nodule’s edge.
Benign lesions have smooth rounded edges, whereas the incidence of
neoplasm increases dramatically in lesions with irregular, spiculated
borders. An increasing incidence of malignancy occurs, ranging from 2093%, depending on the degree of border irregularity
132. Diagnosis
The first step in evaluating a SPN is to try to obtain old chest x-rays for
comparison If this is not possible, and the nodule does not have a classic,
calcified appearance typical of a granuloma or hamartoma, then further testing or
a period of careful observation must be undertaken.
A CT scan can help distinguish the pattern of calcification, and classify lesions as
“indeterminate” based on the presence of stippled or eccentric calcification and
medium density, or “benign” based on the presence of fat density typical of a
hamartoma.
The most common CT finding in early stage adenocarcinoma and squamous cell
carcinoma of the lung is that of a solitary pulmonary nodule which enhances after
administration of IV contrast. In small cell carcinoma, however, hilar and
mediastinal adenopathy secondary to metastases is the most common CT
presentation. The presence of irregular margins, associated air bronchogram,
convergence of the surrounding structure, or the involvement of three or more
blood vessels is more likely in malignant lesions.
If a period of observation is chosen, chest x-rays, and possibly serial CT scans,
should be done at 3-month intervals over at least a two year period to
determine if any change in the size of the nodule has occurred. An increase in
the diameter of the nodule by 25% indicates a doubling of the mass
volume a sign of malignancy.
133. Diagnosis - PET
Because of the difficulty with noninvasive diagnosis of the
SPN, new radiologic techniques are being studied, including
positron emission tomography imaging (PET), which is able to
distinguish benign from malignant pulmonary nodules by
measuring 18-fluorodeoxyglucose (FDG), and by showing
increased FDG uptake and retention in malignant cells. PET
scanning is a valuable, noninvasive tool with a 95% sensitivity
for identifying malignancy and a specificity of 85% or greater.
However, false positive results may be obtained in lesions
containing an active inflammatory process (for example a
reactive lymphadenopathy), and this diagnostic modality is not
generally available.
134. SPN
When to Refer
Once the decision has been made that the patient’s SPN may represent a
malignancy, a histologic diagnosis is needed. If the patient’s SPN has
characteristics strongly suggesting malignancy, and there are no
contraindications to surgery, refer to a thoracic surgeon.
In most other circumstances refer to a pulmonologist for further workup.
Diagnostic procedures may include: fiberoptic bronchoscopy aided by
fluoroscopy, or CT-guided transthoracic fine needle aspiration. The yield
of these procedures in the diagnosis of the small solitary pulmonary nodule
(< 1.5 cm in diameter) is about 40% for fiberoptic bronchoscopy, and 50%
for fine needle aspiration. The incidence of pneumothorax requiring chest
tube insertion from bronchoscopic transbronchial biopsy is about 5% and
from needle aspiration about 25%, depending on patient characteristics and
variation of local physician technique.
Thoracoscopic resection or thoracotomy is needed for diagnosis in about
20% of patients, in whom the less invasive techniques were not successful.
135.
A 43-year-old woman is evaluated because of an abnormal chest
radiograph taken before an elective hysterectomy for fibroids. She has no
previous history of pulmonary disease. Her cardiac and pulmonary review
of systems is unremarkable. The patient smoked one pack of cigarettes per
day from age 16 to 33 years, but has not smoked since then. On physical
examination, her blood pressure is 120/60 mm Hg and the lung fields are
clear. The remainder of the examination is unremarkable. Her laboratory
evaluation, including a complete blood count and chemistry profile, is
normal. Spirometry shows forced expiratory volume in 1 sec (FEV1), 2.72
L (84% of predicted); forced vital capacity (FVC), 3.68 L (98% of
predicted); and FEV1/FVC ratio of 74%. Chest radiography shows an
approximately 1-cm nodule in the left lower lobe periphery. There are no
previous radiographs. High-resolution helical computed tomography (CT)
of the 1.2-cm lesion in the left lower lobe is shown. The full chest CT
shows no evidence of mediastinal adenopathy. Which of the following is
the best management option?
( A ) Bronchoscopy with transbronchial biopsies
( B ) No further studies are needed
( C ) Repeat high-resolution CT in 3 months
( D ) Resection of the lesion with video-assisted thoracoscopic surgery
( E ) Percutaneous fine needle aspiration of the lesion
136.
The likelihood of a solitary pulmonary nodule
being malignant substantially decreases if the
lesion is small (approximately 1cm), has
smooth borders, is located in a lower lobe,
and, most importantly, has central
calcification.
Observation at 3 month intervals for 2 years to
ensure stability of the finding is sufficient!!
138. EFFUSIONS
EXUDATES: pleural fluid [protein] / plasma
[protein] > 0.5 and/or pleural fluid
[LDH] / plasma [LDH] > 0.6 and/or pleural fluid
LDH >200 or >2/3 of serum LDH
TRANSUDATES – Nephrotic syndrome, CHF,
Atelectasis, Cirrhosis (Hydrothorax)
EMPYEMA
Diagnosis By thoracentesis. Except in known
CHF, must be done in all pleural effusions.
139.
A 56-year-old man with chronic alcoholism is evaluated because of fatigue, decreased appetite, and
episodes of sweating. He has a cough productive of purulent, foul-smelling grayish-green sputum and
describes heaviness in the right lower chest. The patient has reduced his activity, but only missed 2 days of
work as a painter because of his illness. On physical examination, his temperature is 37.4 °C (99.3 °F),
pulse rate is 84/min, respiration rate is 14/min, and blood pressure is 132/85 mm Hg. There is dullness to
percussion at the right lateral and posterior lung base associated with decreased breath sounds. Chest
radiography shows a large right-sided pleural effusion and a small parenchymal infiltrate. The effusion did
not layer along the chest wall in a lateral decubitus film. A thoracentesis is performed, and the leukocyte
count is 32,500/μL with83% neutrophils, the pH is 7.12, and glucose is 25 mg/dL. The fluid is sent for
culture, and antibiotics are begun.
Which of the following should be done next to manage the pleural fluid?
( A ) Insertion of a pigtail catheter into the pleural space
( B ) Insertion of a large-bore chest tube
( C ) Repeat thoracentesis if the pleural effusion does not improve in 48 hours
( D ) Open surgical decortication
( E ) Reevaluation of the pleural effusion in 7 days
140. Ans.
Frankly purulent pleural fluid, pleural fluid pH
<7.20, and,possibly, loculated collections of
fluid are indications for chest tube drainage